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SUMMARY 
Transcription by RNA polymerase (Pol) II begins with binding of general transcription 
factors to the promoter DNA. It is believed that binding of the TATA box-binding pro-
tein (TBP) to the TATA box nucleates pre-initiation complex (PIC) assembly. Howev-
er, genome-wide analysis revealed that a classical TATA box occurs in only 15% of 
all Sacchoromyces cerevisiae (Sc) promoters. Since TBP is absolutely required for 
PIC assembly this raises the question of how the PIC is assembled at the other 85% 
TATA-less promoter. In this study, a novel conserved DNA element, the GA element 
(GAE), is characterized. This element is present in one third of all yeast promoters 
and is mutually exclusive to the TATA box. The GAE – characterized by one guanine 
followed by at least four adenines – can occur in multiple copies in the core promoter 
region. Its distance to the transcription start site (TSS) is similar to the distance be-
tween the TATA box and the TSS. The TATA-less model promoter TMT1 contains a 
GAE, binds TBP and supports formation of a TBP-TFIIB-DNA complex. Moreover, 
mutation of the GAE and its surrounding nucleotides decreases transcription in vivo 
and in vitro. Additionally, a 32-nucleotide promoter region containing the GAE can 
functionally substitute for the TATA box in a TATA box-containing promoter, both in 
vivo and in vitro. This demonstrates a direct role of the GAE-containing region in 
transcription and identifies the GAE as a conserved core promoter element in TATA-
less Pol II promoters. 
Transcription by Pol III begins with binding of TFIIIC to the promoter. Next, TFIIIB 
(composed of TBP, Brf1 and Bdp1) is recruited, followed by Pol III and the initiation 
complex is formed. Pol III synthesizes tRNAs and other small non-coding RNAs such 
as 5S rRNA and thereby regulates protein synthesis on different levels. Dysregula-
tion of transcription by Pol III has been linked to cancer and mutations in genes en-
coding Pol III subunits and tRNA processing factors cause different forms of neuro-
genetic diseases. Here, an autosomal-recessive disease is described characterized 
by cerebellar, dental and skeletal anomalies possibly caused by identified biallelic 
missense alterations of BRF1 in the patients. These mutations impair cell growth, 
reduce Brf1 occupancy at tRNA gene promoters and decrease Pol III-dependent in 
vitro transcription in the model organism Sc. These results indicate that hypomorphic 
BRF1 mutations cause a neurodevelopmental syndrome and that transcription by 
Pol III might be required for normal cerebellar and cognitive development. 
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1 GENERAL INTRODUCTION 
1.1 Transcription by RNA Polymerases 
Transcription is one of the key events in the central dogma of molecular biology. This 
dogma was firstly described by Francis Crick in 1970 [1]. He proposed a basic 
scheme for the general transfer of information from deoxyribonucleic acid (DNA) via 
ribonucleic acid (RNA) to protein conserved throughout the three domains of life 
(Figure 1).  
 
 
 
Figure 1 Central dogma of molecular biology proposed by Francis Crick. Adapted 
from Crick, 1970, Nature [1]. 
Solid arrows represent general transfer of information, dotted arrows special transfer. Gener-
al transfers occur in all cells whereas special transfers occur only under certain circums-
tances. General transfers include replication of DNA, transcription from DNA into RNA and 
translation of messenger RNA into protein amino acid sequence. Special transfers like RNA 
to DNA transcription can occur in virus-infected cells. 
 
The information encoded in the DNA is inherited by DNA duplication (replication) and 
read out by RNA polymerases which transcribe the DNA into RNA (transcription). 
Protein-coding messenger RNA (mRNA) is translated by ribosomes into an amino 
acid sequence (translation), which folds into proteins with a 3D structure. All three 
steps are highly regulated and depend on each other. Francis Crick also suggested 
rare special transfers, e.g. transcription from RNA to DNA in virus-infected cells [1]. 
  
1 GENERAL INTRODUCTION 
 
 
2  
 
1.1.1 RNA polymerases 
RNA polymerases can be either single- or multi-subunit enzymes. Both groups do 
neither show sequence conservation nor structural homology [2].  
Single-subunit Polymerases are usually found in bacteriophages, chloroplasts or  
mitochondria. Recently, the structure of the human mitochondrial RNA polymerase 
was solved revealing besides a lot of similarities differences to the T7 RNA polyme-
rase structure [3]. 
Multi-subunit polymerases are present in archaea, prokaryotes and eukaryotes. In 
archaea and prokaryotes, all cellular RNA is synthesized by one RNA polymerase 
whereas in eukaryotes, this process is divided between at least three different poly-
merases: RNA polymerase I, II and III (Pol I, II and III). Interestingly, although they 
share a conserved catalytic core [4] they differ in the number of subunits and sensi-
tivity to the inhibitor -amanitin [5]. Pol I (14 subunits) is sensitive to high concentra-
tions of -amanitin whereas Pol II consists of 12 subunits and is inhibited by low con-
centrations of -amanitin. Pol III is the largest polymerase composed of 17 subunits 
and is not affected by -amanitin at all [5]. The nucleolar Pol I transcribes a locus 
encoding for the 5.8S, 18S and 28S ribosomal RNA (rRNA). Pol II and Pol III are 
both located in the nucleoplasm. The former synthesizes mRNAs and some small 
nuclear RNAs whereas the latter is responsible for transfer RNA (tRNA), 5S rRNA 
and other small RNA (snRNA) transcription. In plants, there were recently discovered 
Pol IV and V synthesizing RNAs involved in non-coding RNA-mediated gene silenc-
ing processes [6].  
The transcription mechanism shows different level of complexity between the three 
domains of life. In all cases, additional regulatory proteins are necessary. Archaea 
require TFB and the TATA box-binding protein (TBP) for proper RNA polymerase 
recruitment and transcription initiation [7]. Prokaryotic RNA polymerases need the 
sigma factor for binding to the promoter sequence and subsequent initiation [8]. In 
eukaryotes, diverse factors are needed to distinguish between the different polyme-
rases and to assure specific regulation of transcription. This can be achieved through 
distinct DNA elements and a lot of more factors involved in transcription than in 
archaeal and prokaryotic transcription [9]. These factors are specific for Pol I, II and 
III but have the same function. Interestingly, there is only one protein – TBP – being 
shared and essential for transcription by all three RNA polymerases (Table 1) [10].  
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Table 1 Yeast RNA polymerase subunits and initiation factor homologies. 
Adapted from Vannini and Cramer, 2012, Molecular Cell [11]. 
 
Pol I Pol II Pol III Function 
A49 (N-terminal domain) 
and A34.5 
TFIIF C37 and C53 
Initiation complex stabiliza-
tion, start site selection 
A49 (C-terminal domain) TFIIE C82 and C34 Open complex stabilization 
Rrn7 TFIIB Brf1 
TBP/polymerase binding, 
DNA opening, start site se-
lection 
TBP TBP TBP 
DNA binding, nucleation of-
PIC assembly 
 
1.1.2 Transcription by RNA polymerase I 
RNA polymerase I-dependent transcription is responsible for synthesizing up to 80% 
of the total cellular RNA but transcribing only a single gene in a transcription foci of 
the nucleus, the nucleolus [12]. This gene encodes for up to 200 – 300 copies of one 
precursor rRNA, which is spliced into the 5.8S, 18S and 28S rRNA. The Pol I promo-
ter sequence is not well conserved but contains two distinct functional elements: the 
core promoter sequence (core) and the upstream promoter element (UE) [12]. In 
yeast, formation of the pre-initiation complex requires binding of the upstream activat-
ing factor (UAF), TBP and TBP associated factors (TAFs, called core factor (CF) in 
yeast) to the promoter sequence, which then recruits Pol I resulting in the initiation 
complex (IC) (Figure 2). RNA polymerase I transcription is highly regulated and influ-
ences or even regulates cell growth. That makes it to an interesting field for cancer 
research [12].  
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Figure 2 Scheme of RNA polymerase I IC and promoter architecture in yeast. 
Adapted from Moss et al, 2007, Molecular and Cellular Life Sciences [12]. 
In yeast, RNA Polymerase I PIC assembly begins with binding of the upstream activating 
factor (UAF) to the upstream element (UE). Afterwards, TATA box-binding protein (TBP) and 
the core factor (CF) are recruited to the core sequence (Core) and form a stable complex 
with the DNA. The core factor is composed of Rrn6, 7 and 11. In humans, this factor is called 
SL-1 and composed of at least five TATA box-associated factors (TAFs). Eventually, Pol I is 
recruited in an initiation-competent form through Rrn3-mediated interaction with the core fac-
tor, the IC is formed and transcription is initiated. 
 
1.1.3 Transcription by RNA polymerase II  
RNA polymerase II-dependent transcription is the first step in eukaryotic gene ex-
pression. Pol II transcribes the protein-coding genes into mRNA, which is then trans-
lated into an amino acid sequence. It is a highly regulated process and depends not 
only on general transcription factors (GTFs) but also on positive and negative cofac-
tors like chromatin modifiers and coactivator complexes (e.g. Mediator or SAGA), 
elongation factors and RNA processing and termination factors [13].  
The GTFs TFIIA, -B, -D, -E, - F, -H and -S are required for promoter recognition, 
melting, transcription start site (TSS) selection and primary RNA synthesis [13] 
(Table 2). 
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Table 2 The general transcription factors and their function. Adapted from Tho-
mas and Chiang, 2006 [13]. 
 
Factor Subunits Function 
TFIIA 3  Stabilizing TBP-DNA interaction, coactivator 
TFIIB 1  Stabilizing TBP-DNA interaction, recruits Pol II with 
TFIIF, TSS selection 
TFIID TBP and 14 
TBP asso-
ciated factors 
(TAFS) 
Core promoter binding, nucleates PIC assembly, coacti-
vator, protein kinase, histone acetyltransferase 
TFIIE 2  Recruits TFIIH, stimulates TFIIH activity, involved in 
promoter clearance 
TFIIF 2  Associated with Pol II, recruits TFIIE and TFIIH, func-
tions with TFIIB and Pol II in TSS selection, facilitates 
Pol II promoter escape, enhances elongation efficiency 
TFIIH 10  ATPase/helicase activity for promoter melting and clear-
ance, kinase activity for Pol II CTD phosphorylation, 
transcription-coupled nucleotide excision repair 
TFIIS 1  Stimulates PIC assembly at some promoters and intrin-
sic cleavage activity of Pol II to release it from transcrip-
tional arrest 
 
The RNA polymerase II promoter region is the most complex of all RNA polymeras-
es. It is divided into a regulatory and a core promoter region. The regulatory region is 
responsible for ensuring accurate response to environmental stimuli and cell-specific 
transcription. The core promoter is sufficient to direct transcription in vitro and is 
bound by the GTFs in a distinct order [13]. Depending on the core promoter elements 
and the distribution of the TSSs Pol II promoters can be classified into TATA box 
containing and TATA-less promoters [14] or focused and dispersed promoters[15]. 
 
Transcription can be described as a cycle with four main steps (Figure 3): (1) tran-
scription initiation, (2) elongation, (3) termination and (4) recycling of the machinery 
for re-initiation [16].  
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Figure 3 RNA polymerase II transcription cycle. Adapted from Nechaev and 
Adelman, 2011 [17]. 
RNA polymerase II enters the transcription cycle during PIC formation and transcription is 
initiated (1). The re-initiation complex consisting of GTFs and coactivators remains bound to 
the template. After a potential pause state during early elongation Pol II proceeds into pro-
ductive elongation (2). Finally transcription is terminated (3) and the released Pol II can bind 
again to the re-initiation complex (4). 
 
Before transcription initiation, the pre-initiation complex (PIC) has to assemble on 
RNA polymerase II promoters (Figure 4). During activation, gene-specific transcrip-
tion factors recruit co-activator complexes and TFIID, thereby facilitating PIC assem-
bly at the promoter. A subunit of TFIID, TBP, binds to the TATA box, which is located 
upstream of the TSS, and nucleates PIC assembly [18, 19]. TBP causes a kink in the 
DNA, which facilitates binding of the following GTFs [20]. Subsequent TFIIA binding 
leads to TBP-DNA complex stabilization enhanced through TFIIB binding. TFIIB re-
cruits afterwards RNA polymerase II together with TFIIF to the PIC. PIC formation is 
completed through binding of Mediator, TFIIH and TFIIE. Finally, TFIIH opens the 
promoter DNA and the first nucleotides (NTPs) are incorporated and TFIIB assists in 
TSS selection [16]. After promoter escape and transition into productive elongation, 
synthesis is terminated with the help of special termination factors. Some of the 
GTFs and Mediator remain associated with the DNA facilitating RNA polymerase II to 
enter a new round of transcription after termination [16]. The synthesized pre-mRNA 
is capped and processed (co-transcriptionally) before export to the cytoplasm [21].  
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Figure 4 Scheme of RNA polymerase II PIC and promoter architecture. Adapted 
from Bywater et al., 2013, Nature Reviews Cancer [22]. 
TBP (dark green, component of TFIID, green) nucleates PIC assembly by binding to the 
DNA. Subsequently, TFIIA and TFIIB bind to the TBP-DNA complex and strengthen this inte-
raction. TFIIB recruits Pol II in complex with TFIIF. Thereby, Pol II is positioned over the TSS. 
Finally, Mediator, TFIIH and TFIIE are recruited and complete PIC assembly. TFIIH melts the 
promoter DNA and transcription by Pol II is initiated. 
 
Besides the regulation of transcription initiation through factors and DNA elements, 
elongation and termination can be regulated as well. Modifications, like phosphoryla-
tion, glycosylation and peptidyl-prolyl isomerization, of the Rbp1 C-terminal domain 
(CTD) play a major role for transitions in the transcription cycle resulting in the term 
‘CTD code’ [23, 24]. The CTD is composed of multiple tandem hepta-peptide repeats 
of the sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, which are conserved from 
yeast to human only differing in the number of repeats and their deletion is lethal [23].  
 
1.1.4 Transcription by RNA polymerase III  
RNA polymerase III transcribes genes encoding for short RNAs not longer than 400 
base pairs (bp) having a catalytic or structural function, for example tRNAs, 5S rRNA 
and snRNAs functioning in the splicing machinery [25]. Depending on the promoter 
type TFIIIA, B and C and SNAPc (small nuclear RNA-activating protein complex) are 
needed for transcription [25]. In short, the promoter types differ in promoter architec-
ture but all involve direct or indirect TFIIIB recruitment to the promoter DNA [26] 
(Figure 5). TFIIIB is a three protein complex composed of TBP, B-related factor 1 
(Brf1) and B double prime 1 (Bdp1). 
1 GENERAL INTRODUCTION 
 
 
8  
 
 
 
Figure 5 Scheme of RNA polymerase III ICs and promoter types. Adapted from 
Schramm and Hernandez, 2002, Genes and Development [25] and Bywater et al., 2013, 
Nature Reviews Cancer [22]. 
The composition of the Pol III ICs depends on the promoter type. The 5S rRNA promoter 
belongs to promoter type 1, where TFIIIA is recruited to the internal control region (ICR) 
which recruits and orientates TFIIIC and TFIIIA. Finally, Pol III is recruited by TFIIIB to the 
transcription start site (TSS) and transcription is initiated. TFIIIB is composed of TBP, Brf1 
and Bdp1. In type 2 promoters, like tRNA genes, TFIIIC is recruited through the gene-internal 
A- and B-box which recruits TFIIIB. Again Pol III is recruited by TFIIIB and transcription is 
initiated. For a small number of Pol III genes, like snRNA genes, the promoter is located 
gene-external (promoter type 3) and contains a TATA box (TATA) and a proximal sequence 
element (PSE). In humans, a TFIIIB-like factor (Brf2 instead of Brf1) binds to the TATA box 
and the SNAPc binds to the PSE. 
 
The promoter type I is characterized by an internal control region (ICR) consisting of 
the A-box, an intermediate element and the C-box. TFIIIA binds to the ICR and  
recruits TFIIIC, which in turn recruits TFIIIB [27]. Pol III is eventually recruited through 
interaction with TFIIIB to the promoter and transcription is initiated. The 5S rRNA 
promoter is the only known type I promoter. 
A typical type II promoter consists of an A-Box and B-Box located 12-20 bp down-
stream of the TSS and 30-60bp downstream of the A-Box, respectively. They serve 
as binding sites for TFIIIC, which recruits TFIIIB followed by Pol III. tRNA genes and 
a few viral RNA genes belong to this promoter class. 
In higher eukaryotes, additional type III promoters are defined by gene-external up-
stream elements – the TATA-box and the proximal sequence element (PSE). In this 
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case, TFIIIB is recruited through the upstream binding factor SNAPc and not TFIIIC 
and binds to the TATA box. Moreover, this TFIIIB contains Brf2 instead of Brf1, a 
slightly different variant of Brf1 [28]. Examples for type III promoters are the U6 
snRNA gene and 7SK gene. 
Termination of Pol III-dependent transcription is achieved through a stretch of Thy-
mines and involvement of several factors resetting RNA polymerase III for re-
initiation [29]. 
 
1.1.5 Regulation of initiation of transcription by RNA polymerase 
RNA polymerase transcription initiation needs to be tightly regulated otherwise it can 
lead to diseases like cancer, autoimmunity or neurological diseases [30]. Regulation 
occurs on different levels but in the end it all leads to restricting RNA polymerase 
access to the DNA, in other words regulating transcription initiation.  
Trans-acting factors, DNA binding transcription factors, bind to cis DNA elements 
thereby regulating recruitment of the transcriptional machinery. On the first level of 
regulation, different chromatin modifications restrict or enhance binding of gene-
specific activators which in turn make the cis DNA elements accessible for GTFs and 
Polymerases [31]. On the second level, cis DNA elements regulate binding of these 
gene-specific transcription factors and the general transcription machinery. Cis DNA 
elements located in close proximity to the TSS are called core promoter elements 
[32]. They serve as binding platforms for the transcription factors and the RNA poly-
merase, hence determining the point of IC assembly. In case of transcription by Pol II 
combinations of different core promoter elements can influence strength and rate of 
transcription initiation [32].  
Additionally, general transcription factors can regulate transcription by themselves as 
well, e.g. phosphorylation of yeast TFIIB at Serine 65 leads to initiation of transcrip-
tion by Pol II [33] or recruitment of TFIIIB by TFIIIC results in Pol III recruitment fol-
lowed by initiation [34]. 
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1.2 Aims of this Study 
The first part of this study concentrates on the identification and characterization of a 
new core promoter element in Saccharomyces cerevisiae (yeast). Transcription by all 
three RNA polymerases requires the binding of TBP, which nucleates PIC assembly 
[10]. Although the name – TATA box binding protein – implies binding to the consen-
sus TATA box sequence TATAWAWR only 10 – 15% of all yeast core promoters  
actually encode that sequence [14, 35]. Thus, promoters can be divided into TATA 
box-containing and TATA-less promoters which are linked to SAGA-dominated and  
TFIID-dominated transcription, respectively [36]. Based on the observation that  
TATA-less core promoters also require TBP in its complex TFIID [10, 37, 38], it was 
hypothesized that TATA-less core promoters contain DNA elements that are func-
tionally similar to the TATA box in promoting PIC assembly and transcription by Pol 
II. Although the GTFs are highly conserved throughout eukaryotes, alternative core 
promoter elements binding TBP could not be identified in yeast, so far. 
To identify and functionally characterize a region in TATA-less yeast core promoters 
that contain a novel conserved core promoter element, is bound by TBP and required 
for Pol II-dependent transcription a combination of bioinformatics, in vivo reporter 
gene assays and in vitro biochemistry was used.  
The second part of my study focuses on a general transcription factor of the RNA 
polymerase III machinery – Brf1, component of TFIIIB. Transcription by Pol III begins 
with TFIIIB recruitment through TFIIIC to a Pol III promoter. TFIIIB recruits in turn 
Pol III and transcription is initiated. Dysregulation of this recruitment due to overex-
pression of transcription factors or TFIIIB can lead to cancer [22]. Interestingly, only a 
few human genetic diseases are known to be caused by mutations in genes encod-
ing components of the Pol III or tRNA processing machineries. The general principle 
of Pol III-dependent transcription is conserved from yeast to humans making it possi-
ble to investigate phenomena observed in humans in yeast and to draw general con-
clusion from findings in yeast to higher eukaryotes.  
In human siblings showing all the same autosomal-recessive syndrome character-
ized by cerebellar, dental and skeletal anomalies, novel point mutations in BRF1 – 
potentially causing this disease – were identified by whole exome sequencing.To in-
vestigate these mutations and their impact on transcription by Pol III, they were intro-
duced and characterized with in vivo assays and in vitro transcription in yeast. 
1 GENERAL INTRODUCTION 
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1.3 Additional Contributions 
Additional experiments resulting in a co-authorship are described in more detail in 
section 3. Briefly, for the investigation of the Pol II open complex architecture, com-
posed of a TATA box-containing mismatch DNA, TBP, Pol II, TFIIB and TFIIF, it was 
shown that the used fluorescently labeled TFIIB variant is functional in an in vitro 
transcription assay. In this study, a single-molecule approach was applied using sin-
gle-molecule Förster resonance energy tranfer experiments and nano-positioning 
analysis [39]. The authors could determine the position of the TBP-DNA complex in 
relation to Pol II – it is located above the cleft – and suggested large structural 
changes during the initiation to elongation transition caused by a high intrinsic flexibil-
ity of TFIIB.   
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2 A CONSERVED GA ELEMENT IN TATA-LESS RNA POLYME-
RASE II PROMOTERS 
2.1 Introduction 
The first described and best characterized core promoter element in RNA polyme-
rase II transcription is called TATA box referring to its prominent sequence TATA 
[40]. It is conserved through all domains of life – even in viruses– and bound by TBP, 
the TATA box-binding protein [15, 41-43]. In humans, the TATA box is located at a 
defined position of 30 nucleotides (nt) upstream of the TSS. In yeast, contrary, the 
distance between TATA box and TSS or the point of PIC assembly and initiator 
(INR), respectively, can vary from 40 to 120 nt upstream of the TSS. It is suggested 
that Pol II scans the DNA until it reaches the Initiator region before transcription is 
initiated [44]. As already mentioned, TBP binding is the first step in PIC assembly 
and essential for transcription initiation. However, recent genome-wide analyses  
revealed that not all but only a small fraction of 10 – 15% of all eukaryotic Pol II pro-
moters encode a TATA box with the consensus sequence TATAWAWR (W = A/T, R 
= A/G) [14, 35].Thus, promoters can be divided into TATA box-containing and TATA-
less promoters which are linked to SAGA-dominated and TFIID-dominated transcrip-
tion, respectively [36]. That is supported by the finding that a TATA box is not strictly 
required for TFIID-dependent activity of a yeast model promoter [45]. Moreover, a 
recent study of the TATA-less yeast RPS5 promoter showed that functionally redun-
dant AT-rich stretches within the core promoter region promote TFIID-dependent 
transcription [46]. Additionally, those AT-rich stretches are proposed to create nuc-
leosome-free regions (NFRs) thereby keeping the core promoter region open for 
binding of the general transcription machinery [47, 48]. 
Since TATA-less promoters require TBP for function [10, 37, 38] and can bind TFIID 
[49], alternative pathways for PIC assembly were proposed [50, 51]. In metazoans, 
many TATA-less promoters contain a downstream promoter element (DPE) and an 
INR, which interact with components of TFIID to facilitate PIC assembly. The INR 
also determines the region of transcription initiation. Both elements are conserved 
but show different consensus sequences throughout species [15, 52]. 
Another core promoter element, called TFIIB-recognition element (BRE), directs the 
binding of the general transcription factor TFIIB to the core promoter. It can be  
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located up- or downstream of the TATA-box [53]. Several more core promoter ele-
ments have been discovered in the last years. Some of them function independent of 
and synergistically with the TATA box and INR, like the X core promoter element 1 
(XCPE1) or the motif ten element (MTE) and the downstream core element (DCE), 
respectively [54, 55].  
A summary of all known core promoter elements can be found in Figure 6. 
 
 
 
Figure 6 Core promoter elements in RNA polymerase II transcription. Adapted 
from Juven-Gershon et al, 2008, Current Opinion in Cell Biology [15]. 
Summary of all known promoter elements. BREu/d – TFIIB recognition element up- or down-
stream of the TATA box; TATA – TATA box; INR – Initiator, XCPE1 – X core promoter ele-
ment 1; MTE – motif ten element; DCE – downstream core element; DPE – downstream core 
promoter element. +1 and the arrow mark the transcription start site of a protein-coding gene. 
 
Interestingly, there is no universal core promoter element, since all known core pro-
moter elements usually occur only in a fraction of Pol II promotersand functional 
combinations of several core promoter elements are widespread. The most common 
one is probably the INR. Although the GTFs are highly conserved throughout  
eukaryotes, besides the TATA box and INR other core promoter elements have not 
been identified in yeast so far.  
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2.2 Results and Discussion 
2.2.1 Many TATA-less yeast promoters contain a conserved GAE 
In contrast to higher eukaryotes, where the distance between the TATA box and the 
TSS is fixed at around 30 nucleotides, a variable distance of 40−120 nucleotides is 
observed in the yeast Sacchormyces cerevisia (Sc), apparently due to a TSS scan-
ning mechanism [44]. This has hampered bioinformatic discovery of core promoter 
elements other than the TATA box in yeast. To systematically search for a core pro-
moter motif that could be functionally similarto the TATA box in TATA-less yeast 
promoters, four criteria were defined: (1) The motif should peak within a core promo-
ter window of -110 to -50 nucleotidesrelative to the TSS. (2) The motif occurrence 
should be anti-correlated to the TATA box. (3) The motif should be frequent in this 
region in TATA-less promoters. (4) The motif should be highly conserved. 
For each of the 1024 possible 5-mers, the frequency of occurrence within the core 
promoter window and the Matthews correlation coefficient with the TATA box (con-
sensus TATAWAWR) were calculated. This search identified a DNA element com-
prising one guanine followed by four adenines (GAAAA) as being most highly anti-
correlated to the TATA box (Figure 7A, criterion 1 and 2).  
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Figure 7 Many TATA-less yeast promoters contain a conserved GAE.  
(A) Anti-correlation between different 5-mers and the TATA box in Sc core promoters. The 
GAE is marked by a green triangle. (B) Frequency of DNA 5-mers and their conservation 
between five closely related yeast species (Sc, S. paradoxus, S. mikatae, S. kudriavzevii, S. 
bayanus) in the core promoter window (-110 to -50 relative to TSS) of 3711 Pol II promoters. 
For comparison, the TATA consensus (TATAWAWR) and GAE-related sequences are shown. 
TATA-related sequences are marked by a purple triangle, GAE-related sequences are 
marked by a green triangle, transcription factor binding sites are marked by a blue square, 
and other 5-mers are marked by an open circle. (C) Percentage of Sc core promoters con-
taining the TATA box, GAE, both elements or none of the elements with and without conser-
vation between five closely related yeast species (left and right column, respectively). (D) 
Occurrence of the TATA box and GAE in 3711Sc Pol II promoters aligned to the TSS. The 
core promoter window used for bioinformatics analyses is highlighted by a blue box. 
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This novel element was termed GA element (GAE). It displays the second highest 
frequency of occurrence in the core promoter window (Figure 7B), only trumped in 
frequency by a subsequence of its longer version GAAAAA (criterion 3).  
Next, the conservation of all 5-mers in the core promoter window among five closely 
related yeast species (Sc, S. paradoxus, S. mikatae, S. kudriavzevii,S. bayanus)was 
analyzed. In the multiple sequence alignments a shift of up to ± 3 nucleotides be-
tween motifs was allowed. Again, the GAE stands out as being the most highly con-
served of all the more frequent 5-mers (Figure 7B, criterion 4). Its degree of conser-
vation is slightly higher than that of the full and partial TATA box consensus (TATA-
WAWR and TATAA) and only a little lower than the rarer consensus binding sites of 
transcription factors Reb1 (ACCCG) and Mbp1 (ACGCG). Therefore, the GAE meets 
all four criteria defined above.  
Sc promoters containing only a GAE are three times more abundant than promoters 
containing only a TATA box (34% vs. 11.7%, respectively, Figure 7C). An overview of 
all GAE-containing promoters is listed in the appendix. When filtered by conservation 
between the five closely related yeast species, 12.6% of promoters still contained the 
GAE, whereas 6.8% contained a TATA box (Figure 7C). The GAE is 3.4 times more 
frequent than expected from a mononucleotide background model calculated on the 
same region. This exceeds the TATA box and an A-stretch of length five, which are 
3.3 times and 2.0 times more frequent, respectively. The presence of a GAE is anti-
correlated with the presence of a TATA box (Figure 7C). Only 0.4% of all promoters 
between those five yeast species contain both elements (Figure 7C). In contrast to 
the TATA box, the GAE can be present in more than one copy in the core promoter 
region (Figure 8) and can contain additional adenines at the 3’end (Table 3). Similar-
ly, a study of the TATA-less RPS5 promoter demonstrated the presence of multiple, 
functionally redundant AT-rich sequences, which were shown to recruit TFIID [46]. 
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Figure 8 The GAE can occur in multiple copies.  
Fraction of sequences with the TATA box (purple) and GAE (green) in at least a given num-
ber of multiple occurrences per sequences in 3711Sc promoters aligned at the TSS. 
 
Table 3 Frequency of the GAE with different length of A-tracts in 3711 Sc core 
promoters. 
 
GAE with A-tract of different length Frequency (%) 
GAAAA 37.3 
GAAAAA 22.6 
GAAAAAA 11.9 
GAAAAAAA 7.3 
 
 
When the annotated promoters are aligned to the TSS, the GAE peaks in the same 
region as the TATA box (Figure 7D). The similar position of the TATA box and the 
GAE with respect to the TSS, and the mutual exclusion of these two elements from 
core promoters suggested a functional similarity of both elements during PIC assem-
bly.  
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2.2.2 A TATA-less yeast promoter that functions in vitro. 
To functionally characterize the GAE in vivo and in vitro, the ScTMT1 promoter, a 
TATA-less promoter with a single GAE in the core promoter region was chosen as 
GAE-containing model promoter. For comparison, the ScHIS4 promoter was used, 
which contains a TATA box and is widely used for in vitro transcription assays [19, 
56-58]. Both TMT1 and HIS4 are involved in amino acid biosynthesis and are regu-
lated by the activator Gcn4. Both promoters were tested in a β-galactosidase reporter 
gene assay, which measures promoter strength in vivo. Both promoters were active 
under standard growth conditions (Figure 9A). Next, it was examined whether the 
promoters also supported Gcn4-activated transcription in vitro. Indeed, not only the 
TATA-containing HIS4 promoter but also the TATA-less TMT1 promoter was active 
(Figure 9B, lanes 2 and 5). Promoter activity depended on Pol II, since the Pol II-
specific inhibitor α-amanitin abolished transcription (Figure 9B, lanes 3 and 6). These 
results establish the TMT1 promoter as the first native TATA-less promoter in yeast 
that is active in an activator-dependent in vitro transcription assay.  
 
 
 
Figure 9 A TATA-less yeast promoter that functions in vitro.  
(A) Promoter activity in an in vivo β-galactosidase reporter gene assay of HIS4 and TMT1 Sc 
promoters. Negative control is background signal of the reporter plasmid without a promoter. 
(B) Promoter activity in an in vitro transcription assay of Sc HIS4 and ScTMT1 promoter us-
ing yeast nuclear extracts. In vitro transcription was carried out with and without recombinant 
Gcn4 activator. To test Pol II specificity of transcription, 0.04 mM α-amanitin was added. 
Specific transcripts from the HIS4 TSS and TMT1 TSS are marked by a and b, respectively. 
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2.2.3 The GAE-containing region is required for promoter function 
To test whether the GAE is required for TMT1 promoter function, several promoter 
mutants were generated (Figure 10A) and their activities were tested in in vivo 
β-galactosidase reporter gene assays. Deletion of the bioinformatically defined  
5-nucleotide GAE had a moderate negative effect on promoter activity (Figure 10B, 
lane 2). Whereas replacing the 5-nucleotide GAE with GGCCG had no apparent de-
fect (Figure 10B, lane 3), mutating the 12-nucleotide GAE-containing region (four and 
three nucleotides up- and downstream, respectively) strongly impaired promoter  
activity (Figure 10B, lane 4). Screening of additional promoter mutants revealed a 
strong dependence of promoter function on the four nucleotides directly upstream of 
the GAE (Figure 10B, lane 9). 
Activity of the TMT1 promoter was also strongly decreased when the guanines in the 
12-nucleotide GAE-containing region were changed to adenines (Figure 10B, lane 
10), generating a poly(dA) stretch. A similar defect in promoter activity was observed 
in activated transcription assays using a nucleosome-free DNA template and yeast 
nuclear extracts (Figure 10C) in vitro. This demonstrates a direct role of the GAE-
containing region in transcription and suggests a function independent of  
nucleosome-dependent promoter accessibility. Thus the GAE-containing region is 
functionally distinct from previously described poly(dA) stretches. Several studies of 
poly(dA:dT) tracts in individual model promoters indicated a role in promoter function 
that is linked to nucleosome positioning [47, 48, 59-61]. Further, a recent theoretical 
genome-wide study described G/C-capped poly(dA:dT) tracts associated with the 
nucleosome-free region of TATA-less promoters in yeast [62]. These tracts were 
suggested to define the center of the nucleosome-free region. However, a distinction 
of a direct effect on nucleosome positioning and indirect effects, such as recruiting 
chromatin remodelers or the transcription machinery, could not be made. Consistent 
with that finding, the deletion of a poly(dA:dT) tract in the ILV1 promoter decreased 
transcription significantly without affecting nucleosome organization in vivo [60]. 
Since the GAE described here appears to overlap with a part of the previously de-
scribed poly(dA:dT) tracts, those tracts that fall in the described core promoter win-
dow may be redefined as GAE. 
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The defects of the GAE deletion, the mutations in the flanking regions, and the polyA 
mutation suggest that TMT1 promoter function is strongly dependent on the se-
quence context in the GAE-containing region. 
 
 
Figure 10 The GAE-containing region is required for promoter function. 
(A) Schematic depiction of the TATA-less TMT1and the TATA-containing HIS4 promoter. TA-
TA box and bioinformatically defined GAE are marked by a black box. The 12-nucleotide 
GAE-containing region is marked by a dashed line. Promoter mutants are shown below the 
sequences. Activity of each variant in in vivo β-galactosidase reporter gene assays is shown 
(wild type activity (++), decreased activity (+) and severely decreased activity (-)). (B) Deter-
mination of the core promoter region required for TMT1promoter function. Activities of wild 
type TMT1 and several mutants in the GAE-containing region in an in vivo β-galactosidase 
reporter gene assay are shown. Negative control is background signal of the reporter plas-
mid without a promoter. (C) Promoter activities in an in vitro transcription assay using a nuc-
leosome-free DNA template and yeast nuclear extracts. 
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2.2.4 The GAE has no inhibitory effect on the HIS4 TATA box-containing pro-
moter 
As shown in Figure 7A – C the GAE is anti-correlated to the TATA box. The mutual 
exclusion of TATA box and GAE appears not to be the result of an inhibitory role of 
GAE. Insertion of the GAE up- or downstream of the HIS4 TATA box had no effect on 
promoter function (Figure 11).  
 
 
 
Figure 11 GAE has no inhibitory effect on the TATA-containing HIS4 promoter. 
Promoter activity in an in vivo β-galactosidase reporter gene assay of the wild type and mu-
tated HIS4 promoter. (A) Schematic depiction of the HIS4 promoter constructs with GAE in-
sertions. (B) Activities of wild type HIS4promoter and insertions of the GAE in the proximity of 
the HIS4 TATA box in an in vivo β-galactosidase reporter gene assay are shown. Negative 
control is background signal of the reporter plasmid without a promoter. 
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2.2.5 A TATA-less promoter is bound by TBP 
Since the GAE and the TATA box occur at similar distances from the TSS,  
it was tested whether the GAE-containing promoter region binds TBP. An electropho-
retic mobility shift assay (EMSA) and fluorescently labeled DNA encompassing 40 
base pairs of HIS4 and TMT1 promoter DNA were used. As expected TBP bound to 
HIS4 DNA, but also to the TATA-less TMT1 DNA (Figure 12A, lane 2 and 8).  
 
 
 
Figure 12 The TATA-less TMT1 core promoter is bound by TBP. 
(A) and (B) Electrophoretic mobility shift assay. A 5’-Cy5-labeled 40 bp double stranded DNA 
of the respective promoter construct was incubated with recombinant TBPcore alone or  
TBPcore and TFIIB. The protein-DNA complex was separated from free DNA by native poly- 
acrylamide gel electrophoresis. Free DNA and bound protein-DNA complexes are indicated. 
 
Both promoter DNAs could also form a stable complex with TBP and TFIIB (Figure 
12A, lane 3 and 9). The observed binding was specific to double stranded DNA 
(Figure 13).  
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Figure 13 Only double stranded templates are bound by TBP and TFIIB.  
Electrophoretic mobility shift assay. A 5’-Cy5-labeled 40 bp single (ssDNA) and double 
stranded (dsDNA) template was incubated with recombinant TBPcore alone or TBPcore and 
TFIIB. The protein-DNA complex was separated from free DNA by native polyacrylamide gel 
electrophoresis. Free DNA and bound protein-DNA complexes are indicated. 
 
As expected, TBP and TFIIB binding was strongly decreased by mutating the TATA 
box of HIS4 (Figure 12A, lane 5 and 6). Mutating the 12-nucleotide GAE-containing 
region also impaired TBP and TFIIB binding (Figure 12B, lane 5 and 6). TBP and 
TFIIB binding was not affected when guanines in the 12-nucleotide GAE-containing 
region were replaced with adenines (Figure 12B, lane 8 and 9). These results show 
that a stretch of adenines is sufficient for TBP binding, but not for promoter activity. 
The guanines in and around the GAE thus appear to have a function distinct from 
TBP binding. This is consistent with the observation that TBP binding does not nec-
essarily correlate with promoter activity [63, 64]. 
 
2.2.6 The GAE-containing region functionally substitutes for the TATA box 
To further investigate the potential functional similarity of the GAE-containing region 
and the TATA box, promoter substitution experiments in vivo and in vitro were per-
formed. The HIS4 TATA box can functionally replace the 12-nucleotide GAE-
containing region in the TMT1 promoter (Figure 14B, lane 3).  
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Figure 14 The GAE-containing region functionally substitutes for the TATA box. 
(A) Schematic depiction of promoter substitution constructs of the TATA-less TMT1and the 
TATA-containing HIS4 promoter. TATA box and bioinformatically defined GAE are marked by 
a black box. Solid and dashed lines represent HIS4 and TMT1 promoter sequences, respec-
tively. TSS of HIS4 and TMT1 are labeled with a and b, respectively. Half-arrows mark primer 
annealing sites for primer extension reaction. (B) Promoter activity in an in vivo β-
galactosidase reporter gene assay and in vitro transcription (txn) assay of the wild type (lane 
1 and 4) and mutated TMT1 and HIS4 promoter. Mutations as indicated in Figure 5A. Nega-
tive control (lane 7) is background signal of the reporter plasmid without a promoter. (C) 
Promoter activity in an in vivo β-galactosidase reporter gene assay and in vitro transcription 
(txn) assay of the wild type (lane 1 and 3) and promoter substitution constructs as indicated 
in Figure 5A. Negative control (lane 6) is background signal of the reporter plasmid without a 
promoter. 
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This substitution does not impair binding of TBP and TFIIB (Figure 15A, lanes 5 and 
6).  
 
 
Figure 15 GAE function depends on promoter context.  
(A) and (B) Electrophoretic mobility shift assay. A 5’-Cy5-labeled 40 bp double stranded DNA 
of the respective promoter construct was incubated with recombinant TBPcore alone or 
TBPcore and TFIIB. The protein-DNA complex was separated from free DNA by native poly- 
acrylamide gel electrophoresis. Free DNA and bound protein-DNA complexes are indicated. 
(C) Promoter activity in an in vivo β-galactosidase reporter gene assay and in vitro transcrip-
tion (txn) assay of the wild type and mutated ScSER3 promoter. The 8-nucleotide TATA box 
of the SER3 promoter was substituted by the 12-nucleotide GAE-containing region of the 
TMT1 promoter. 
 
In contrast, the 12-nucleotide GAE-containing region is neither sufficient for function-
al replacement of the TATA box in the HIS4 promoter (Figure 14B, lane 6) nor for 
binding of TBP and TFIIB (Figure 15B, lane 5 and 6). Similar observations were 
made when replacing the TATA box in the SER3 yeast promoter by the 12-nucleotide 
GAE-containing region (Figure 15C). 
To determine a minimal region in the TMT1 promoter that could substitute part of the 
HIS4 promoter without loss of activity, several HIS4-TMT1 fusion constructs were 
tested (Figure 14B). The TMT1 core promoter fused to the HIS4 upstream activating 
sequence is active both in vivo and in vitro (Figure 14C, lane 4). This suggests that 
regions surrounding the 12-nucleotide GAE-containing region are required for func-
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tion. Indeed, inserting a 32-nucleotide GAE-containing region (14 and 13 nucleotides 
up- and downstream of the GAE, respectively) could maintain partial HIS4 activity 
(Figure 14C, lane 5). Including even longer up- or downstream TMT1 sequences did 
not increase activity (Figure 16).  
 
 
Figure 16 The GAE-containing region can functionally replace the TATA box.  
(A)Schematic depiction of promoter substitution constructs of the TATA-less TMT1and the 
TATA-containing HIS4 promoter. TATA box and bioinformatically defined GAE are marked by 
a black box. Solid and dashed lines represent HIS4 and TMT1 promoter sequences, respec-
tively. TSS of HIS4 and TMT1 are labeled with a and b, respectively. Half-arrows mark primer 
annealing sites for primer extension reaction. (B) Promoter activity in an in vivo β-
galactosidase reporter gene assay and in vitro transcription (txn) assay of the wild type and 
mutated HIS4 and TMT1 promoter. Negative control (lane 8) is background signal of the re-
porter plasmid without a promoter.Specific transcripts from the HIS4 TSS and TMT1 TSS are 
marked by a and b, respectively. 
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This is consistent with the observation that sequence context is critical for TMT1  
activity (Figure 10B). This indicates that the AT-rich sequences flanking the GAE in 
the TMT1 promoter are also important for activity. 
Thus, TMT1 promoter function is highly dependent on sequence context. The GAE-
flanking region and the guanine residues in the 12-nucleotide GAE-containing region 
are crucial for promoter function. Similarly, previous studies have shown that also 
TATA box function and TBP-TATA binding is influenced by TATA-flanking sequences 
[65]. 
 
2.2.7 The GAE correlates with TFIID-dominated genes 
Recent genome-wide studies indicated that activation of TATA-less genes is domi-
nated by TFIID [14, 36]. Consistently, a detailed study of the TATA-less TUB2 pro-
moter had demonstrated a strong TFIID dependence [66]. TUB2 activity was severe-
ly reduced in temperature-sensitive TFIID mutant backgrounds. Insertion of a canoni-
cal TATA box at -55 relative to the TSS could alleviate this defect and restore promo-
ter function. Intriguingly, when the TUB2 sequence is inspected, a conserved GAE is 
present at the exact point of insertion. This is consistent with the finding that the GAE 
is mainly found in TFIID-dominated promoters (Figure 17). 
 
 
 
Figure 17 The GAE correlates with TFIID-dominated genes.  
Percentage of Sc core promoters containing a TATA box, a GAE, both elements or none of 
the elements in SAGA- and TFIID dominated Sc promoter classes [14, 36]. 
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3 BIALLELIC BRF1 MUTATIONS ALTER RNA POLYMERASE III-
DEPENDENT TRANSCRIPTION AND POTENTIALLY CAUSE A NEU-
RODEVELOPMENTAL SYNDROME 
3.1 Introduction 
Pol II-dependent transcription has attracted much attention because its mRNA prod-
ucts are protein-coding, but recent years have seen an increasing interest in the 
Pol III apparatus because of its implication in disease. Increased Pol III-dependent 
transcription has been linked to cell transformation and cancer [67, 68], but only a 
few human genetic diseases are known to be caused by mutations in genes encod-
ing components of the Pol III or tRNA processing machineries. Pontocerebellar  
hypoplasias (PCH) are a heterogeneous group of severe progressive neurodegen-
erative conditions often leading to early death [69]. Nine types of PCH are recognized 
and their associated mutations are predicted to lead to loss of function of tRNA splic-
ing endonuclease. However, the pathomechanism leading to PCH is poorly under-
stood [70]. 
More recently, mutations in the Pol III subunits POLR3A and POLR3B have been 
identified in syndromic hypomyelinating leukodystrophies [71-74]. POLR3A mutations 
lead to a decrease in POLR3A levels and are predicted to interfere with the interac-
tion with other Pol III subunits, which in turn would perturb Pol III-mediated transcrip-
tion. These findings suggest that the central nervous system is vulnerable to changes 
in Pol III-dependent transcription [71]. 
The basal Pol III transcription machinery requires the orchestrated interaction of the 
transcription factors TFIIIB and TFIIIC with Pol III [75, 76]. These factors and the un-
derlying mechanism of transcription initiation are conserved through eukaryotes. In 
short, TFIIIC recognizes and binds to internal promoters of e.g. tRNA genes and then 
recruits TFIIIB. TFIIIB is composed of Brf1, Bdp1 and TBP, each of which is required 
for TFIIIB function in vitro [75]. TFIIIB recruits Pol III for transcription initiation. 
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3.2 Results and Discussion 
3.2.1 Clinical delineation of a cerebellar-dental-skeletal syndrome 
Our collaborators of the University of Ulm, Guntram Borck and colleagues, identified 
four children (three girls and one boy) from two unrelated families with an apparently 
identical syndrome characterized by cerebellar, dental and skeletal anomalies. In 
both families, two affected children were born to unrelated and unaffected parents, 
suggesting autosomal-recessive inheritance. The affected children had strikingly 
similar dysmorphic features, e.g sparse eyebrows, apparently low-set ears, propor-
tionate short stature, microcephaly of prenatal onset, mild-to-moderate intellectual 
disability with speech delay and scoliosis (data not shown). Cranial magnetic reso-
nance imaging revealed cerebellar hypoplasia in all four children. On skull and ortho-
panoramic X-rays they saw dental anomalies, like taurodontism, a specific malforma-
tion of the pulp of molar teeth. Array-CGH did not detect causative copy number vari-
ants (data not shown). They refer to this syndrome as cerebellar-dental-skeletal syn-
drome.  
 
3.2.2 Identification of BRF1 mutations 
Whole exome sequencing was performed in one affected individual from each of the 
two families and detected possibly homozygous or compound heterozygous muta-
tions of the same gene in both affected children in a single gene, BRF1. Each af-
fected child was heterozygous for two variants that predicted missense alterations, 
for a total of four distinct mutations (data not shown). In family 1, the affected siblings 
were compound heterozygous for a maternally inherited c.677C>T mutation and a 
paternally inherited c.776C>T mutation, predicting p.Ser226Leu and p.Thr259Met, 
respectively. In family 2, the affected sisters had inherited a c.667C>T mutation from 
their mother and carried additionally a c.875C>A mutation that was likely transmitted 
from their father, who did not participate in the study. These mutations predict 
p.Arg223Trp and p.Pro292His missense alterations, respectively. The mutations 
were absent from ethnically matched controls as shown by sequencing and not pre-
sent or very rare in public SNP databases. The cerebellar-dental-skeletal syndrome 
is likely a rare disease entity with a specific phenotype. Neither BRF1 mutations in 
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three individuals with clinically overlapping but distinct malformation syndromes nor 
in seven individuals with genetically unresolved forms of PCH were identified (data 
not shown).  
BRF1 encodes a 677 amino acid protein that – together with TBP and Bdp1 – forms 
the transcription factor IIIB (TFIIIB), which recruits Pol III to its templates and is in-
volved in promoter opening [77]. The four missense alterations invariably affect 
amino acids that are conserved in evolution, including orthologs from mouse, rat, and 
zebrafish, but that are not conserved in Brf2. In Saccharomyces cerevisiae Brf1, 
Arg223, Thr259 and Pro292 are conserved, whereas Ser226 is conservatively re-
placed by an alanine [78]. For easier understanding, the human amino acid number-
ing is used throughout the text. The corresponding numbers in yeast Brf1 can be 
found in the Methods section (see Chapter 6). Since Ser226 is replaced by an 
alanine in yeast, all experiments were also carried out with a replacement of alanine 
to serine to investigate position-dependent effects. 
 
3.2.3 BRF1 mutations affect cell growth 
Consistent with a pathogenic nature of the identified missense changes, yeast lack-
ing the chromosomal BRF1 gene and expressing BRF1 with mutations correspond-
ing to Arg223Trp or Pro292His did not grow, whereas the mutation analogous to 
Thr259Met induced a severe growth defect (Figure 18). Yeast cells transformed with 
plasmids containing BRF1 substitutions Ala226Ser (reflecting the human reference 
sequence) or Ser226Leu (as found in family 1) grew as wild type. Thus, two muta-
tions are lethal and another mutation leads to a severe growth defect in vivo, consis-
tent with loss of Brf1 function. To simulate the compound heterozygosity present in 
the families yeast cells were transformed with two distinct plasmids expressing Brf1 
variants Arg223Trp/Pro292His or Ser226Leu/Thr259Met. The combination was either 
lethal or led to a growth defect (Figure 18).  
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Figure 18 BRF1 mutations affect cell growth. 
Spot dilutions of the variants introduced into a Brf1 knockout strain grown at 30°C. Wild type 
(WT) and variant Brf1 were encoded on plasmids. For the combination of two mutations two 
plasmids were used each harboring one mutation and a distinct marker. Although the expe-
riment was done in yeast, the residue numbers correspond to the numbers in the human 
protein for better understanding. 
 
Whereas intellectual disability can be due to mutations in synaptic genes [79, 80], 
recent studies have – to some extent unexpected – highlighted impairments of basal 
cellular functions and pathways such as transcription and translation in the etiology of 
cognitive disorders and neurogenetic syndromes [81]. The growth phenotype caused 
by the identified BRF1 mutations supported the implication of the human biallelic 
missense alterations of BRF1 in the observed cerebellar-dental-skeletal syndrome. 
 
  
3 BIALLELIC BRF1 MUTATIONS ALTER RNA POLYMERASE III-DEPENDENT TRANSCRIPTION AND POTENTIALLY 
CAUSE A NEURODEVELOPMENTAL SYNDROME 
 
 
32  
 
3.2.4 BRF1 mutations are predicted to disturb Brf1-DNA interaction 
The N-terminal region of Brf1 has a role in DNA binding and Pol III recruitment [34], 
is homologous to the Pol II transcription factor TFIIB, and contains an N-terminal zinc 
ribbon domain and two cyclin domains. To investigate whether the altered BRF1 
residues may be important for DNA binding, the mutated BRF1 residues were 
mapped on the known crystal structure of the homologous human TFIIB-TBP-DNA 
complex [82] (Figure 19).  
 
 
Figure 19 Structure of the human TFIIB (green) in complex with TBP (purple) and 
DNA (grey) solved by Tsai and Sigler [82]. 
pdb code 1C9B. hTFIIB is homologue to human Brf1, hence the mutations of Brf1 can be 
mapped on that structure (T259 and S226 in yellow and R223 and P292 in orange). 
 
Residues Arg223 and Thr259 are conserved in human TFIIB and are predicted to 
contact DNA (Figure 19). Residues Ser226 and Pro292 are not conserved, and are 
predicted to be in the proximity of the DNA, although not in direct contact (Figure 19). 
These modelling results suggested that the observed BRF1 mutations would affect 
Brf1 binding to DNA, impair TFIIIB-mediated Pol III recruitment, and reduce Pol III-
mediated transcription.  
 
3.2.5 BRF1 mutations impair Brf1 recruitment to target promoters 
To test whether the identified BRF1 mutations influence Pol III recruitment to target 
gene promoters in vivo, chromatin immunoprecipitation (ChIP) with Tandem Affinity 
Purification (TAP) tagged versions of Brf1 variants was carried out in yeast.  
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Figure 20 BRF1 mutations impair Brf1 recruitment to target tRNA promoters. 
Fold enrichments of ChIP experiments conducted with TAP-tagged Brf1 variants in yeast. 
Although the experiment was done in yeast, the residue numbers correspond to the numbers 
in the human protein for better understanding. (A) Mutation of the non-conserved amino acid 
S226 to leucine (yellow bar), which is an alanine in yeast (conversion to serine, white 
bar).shows no effect in fold enrichment compared to wild type (black bar). (B) Result for mu-
tation of Thr259Met. That leads to a decreased fold enrichment on tRNA genes (blue bar). 
(C) Combination of the two variants resulted in a much lower occupancy of the Ser226Leu 
(light green bar) and Thr259Met (green bar) variant. Summing up both signals (dark green 
bar) still results in less occupancy of the two mutated Brf1 than the wild type Brf1 (black bar). 
 
Consistent with the prediction, the Brf1 variant Thr259Met showed strongly de-
creased promoter occupancy at four tested tRNA loci and a significant decrease in 
occupancy of the U6 snRNA promoter (Figure 20B). The ChIP signals for TAP-
tagged Ala226Ser and Ser226Leu variants were not different from wild-type Brf1 
(Figure 20A), when solely present. However, the mutation Ser226Leu decreased Brf1 
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promoter occupancy in a Thr259Met background (Figure 20C). Although the two 
other Brf1 variants, Arg223Trp and Pro292His, were not tested due to their lethality, 
these results show that the mutations can affect Brf1 occupancy at different Pol III 
promoters in vivo.  
Whether the Brf1 alterations additionally impair TFIIIB assembly through defects in 
Bdp1 or TBP binding remains to be investigated. Interestingly, poly-glutamine encod-
ing trinucleotide repeat expansions in TBP cause autosomal dominant spinocerebel-
lar ataxia, SCA17 [83, 84]. Nevertheless, the pathophysiological dissection of SCA17 
is complicated since TBP is a component not only of TFIIIB, but also of the transcrip-
tion factor complexes involved in Pol I and Pol II-mediated transcription. 
 
3.2.6 BRF1 mutations impair Pol III-dependent transcription 
To test whether the BRF1 mutations identified in the cerebellar-dental-skeletal syn-
drome cause a transcriptional defect, an established in vitro transcription assay was 
used [77]. This assay is based on a nuclear extract from a temperature-sensitive 
yeast strain carrying the Brf1 mutation Trp107Arg. Extracts from this strain are tran-
scriptionally inactive, but addition of recombinant Brf1 protein restores activity on a 
template encoding the native SUP4 promoter (Figure 21).  
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Figure 21 BRF1 mutations impair Pol III-dependent in vitro transcription. 
The upper panel shows a representative gel of the in vitro transcription reaction using a nuc-
lear extract harboring a deficient Brf protein, hence being impaired in Pol III-dependent tran-
scription. Addition of wild type (WT) Brf1 rescues activity whereas the different Brf variants 
and the combinations present in the children show a defect in transcription. The top arrow 
indicates the full-length product whereas the bottom arrow a processed product derived from 
the full-length transcript. The graph below depicts the average of eight independent, quanti-
fied experiments with standard deviations. Asterisks indicate significance determined via 
unpaired t-test, * significant at p≤0.05, ** significant at p≤0.001.The lower panel shows a 
twelve times excess of the Brf protein amount used for this assay separated on an SDS gel. 
Although the experiment was done in yeast the residue numbers correspond to the numbers 
in the human protein for better understanding. 
 
When purified recombinant Brf1 variants were used at the same concentration as 
wild-type Brf1in this assay, far less transcription for the Brf1 variant Arg223Trp was 
observed (Figure 21). Milder, but highly reproducible defects were observed for the 
variants Thr259Met, Pro292His, Ala226Ser, and Ser226Leu (Figure 21). When two 
Brf1 variants were combined, simulating the situation present in the children, tran-
scriptional defects were also observed in this assay (Figure 21). These results dem-
onstrate that Brf1 mutations identified in patients can impair transcription in a well-
defined in vitro transcription assay. 
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Taken together, the identified missense variants are recruited to a much lesser extent 
than the wild type protein to target genes and retain little transcriptional activity, sug-
gesting they are hypomorphic. That is in line with the observation that complete inac-
tivation of processes such as translation initiation or tRNA transcription is not com-
patible with life, suggesting that most disease-causing mutations are hypomorphs 
[81]. 
 
3.2.7 The pathomechanism for the neurodevelopmental syndrome is still  
unclear 
A plausible pathomechanism underlying the cerebellar-dental-skeletal syndrome is a 
reduced steady-state level of tRNAs in the cell due to decreased Brf1 recruitment to 
Pol III promoters and thus impaired transcription by Pol III, which would be predicted 
to impair translation. This may explain the growth defect in yeast and short stature in 
the affected individuals. Whether the major drivers of the phenotype are tRNAs or 
other Pol III-dependent transcripts remains to be determined. Additionally, it is cur-
rently unknown why partial disruption of transcription by Pol III leads to organ and 
tissue specific phenotypes. There are approximately 450 nuclear encoded tRNA 
genes in the human genome for only 61 anticodons specified by the genetic code. It 
has been previously shown that up to 26% of tRNA genes are active in one cell type 
versus another and tRNA expression varies by as much as tenfold among human 
tissues [85, 86]. This suggests the existence of active cell and tissue-specific regula-
tion of Pol III-dependent transcription [87]. Although the genome-wide architecture of 
Pol III-mediated transcription in neurons or specific brain regions is currently un-
known, a pilot study revealed a high overall tRNA expression level in the brain [86]. 
This may at least partially explain the vulnerability of the brain or specific brain re-
gions towards impaired transcription by Pol III or processing of tRNAs. This demon-
strates the important role of Brf1 in transcription by Pol III and brain development. 
Whether other affected tissues, such as the teeth, also show specific tRNA expres-
sion patterns remains to be investigated. Interestingly, dental anomalies such as de-
layed dentition or abnormally placed or shaped teeth are part of the Pol III-related 
leukodystrophies 4H syndrome and LO [71].  
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To sum up, our results define a rare syndrome with cerebellar hypoplasia, growth 
retardation and intellectual disability that is most likely caused by partial deficiency of 
the conserved Pol III transcription factor Brf1. This adds an example to the short list 
of genetic diseases caused by dysregulation of the Pol III machinery, most of which 
predominantly affect the central nervous system. 
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4 ADDITIONAL CONTRIBUTIONS 
In the study of Treutlein et al. [39] single-molecule Förster resonance energy tranfer 
experiments and nano-positioning analysis were used to determine the 3D architec-
ture of a minimal open complex. This consisted of a promoter DNA, including a TATA 
box and an 11 nt mismatch around the TSS, TBP, Pol II, TFIIB and TFIIF. They could 
show that in this minimal open complex the TBP-DNA complex resides above the 
Pol II cleft between the clamp and protrusion domains. Furthermore they suggested 
large overall structural changes during initiation-elongation transition due to the  
intrinsic flexibility of TFIIB.  
For this study a fluorescently labeled TFIIB had to be used. To label TFIIB site- 
specific the Sfp phosphopantetheinyl transferase-catalyzed ybbR-tag technique was 
used [88]. Treutlein et al. introduced labels close to the cyclin domains, termed  
(C-term)- and (122)ybbR. To ensure their activity an in vitro transcription assay with a 
TFIIB temperature-sensitive nuclear extract was performed. This extract is inactive 
under normal reaction conditions. If 5 pmol recombinant TFIIB are supplied its full 
activity is recovered. For this study, the two differently labeled ybbR-TFIIB variants 
were added and their ability to recover the transcriptional activity was tested. Both 
variants support transcription on wild type level (Figure 22). Thus, the complexes 
used in this study contain a functional TFIIB. 
 
 
 
 
Figure 22 In vitro transcription of ybbR TFIIB variants. Treutlein et al., 2012, Mol 
Cell [39]. 
In vitro transcription assay testing HIS4 promoter activity of TFIIB-ybbR mutants. Nuclear 
extract (NE) from wild type (WT) yeast strain shows full in vitro transcription activity (lane 1), 
whereas NE from a TFIIB temperature-sensitive yeast strain is essentially inactive (lane 2). 
Transcriptional activity can be restored when recombinant WT TFIIB and the mutants TFIIB-
(C-term) ybbR and TFIIB-(122) ybbR are supplied (lane 3-5). 
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5 CONCLUSION AND OUTLOOK 
In the first part of this study, a novel core promoter element in yeast, the GA element 
(GAE), was characterized. The GAE is found almost exclusively in TATA-less promo-
ters. It is characterized by a guanine followed by a poly(dA)-stretch of at least four  
adenines. Similar to TATA box-containing promoters, the GAE-containing TMT1 
promoter is bound by TBP and supports formation of a TBP-TFIIB-DNA complex. 
Further in vitro and in vivo analysis showed a function of the GAE-containing region 
in TATA-less RNA polymerase II transcription. Moreover the GAE is mainly found in 
TFIID-dominated promoters. Together with the anti-correlation with canonical TATA 
boxes, this suggests a functional similarity of the TATA box and the GAE-containing 
region. 
Several studies studies have linked poly(dA:dT) tracts to the function of defining the 
center of the nucleosome-free region, or in other words having a function in nucleo-
some positioning [47, 48, 59-61]. Since the GAE might also be seen as a poly(dA:dT) 
tract, it is important to note that the in vitro transcription experiments were done on a 
nucleosome-free template. Generating a poly(dA:dT) tract or mutation of the GAE-
containing region resulted in decreased transcriptional activity. This demonstrates a 
direct role of the GAE-containing region in transcription, and suggests a function  
independent of nucleosome positioning. 
This is the first time that a TATA-less promoter is used for in vitro transcriptional 
analysis and that an element with a function similar to the TATA box is described. In 
the future, the TMT1 model promoter can be used for further in vitro studies of TATA-
less transcription in comparison to TATA box-dependent transcription. Additionally, 
several aspects of GAE-dependent transcription remain to be elucidated.  
First, it is still unclear where and in which orientation TBP and TFIIB bind to the GAE-
containing region. This can be addressed by performing site-specific cleavage expe-
riments or DNAse I footprinting [89]. For site specific cleavage, the protein is labeled 
at an (introduced) cysteine residue. If this residue is close to DNA in a protein-DNA 
complex, Cu2+-ion addition leads to site-specific cleavage of the DNA. The DNA, la-
beled with radioactivity on one strand, can be separated on polyacrylamide gels re-
vealing the cleavage site via its length. For DNAse I footprinting, a protein-DNA com-
plex is formed and DNase I is added, which digests the uncovered DNA. Subse-
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quently, the radioactivity-labeled fragments are separated on polyacrylamide gels 
where the region protected by the proteins can be determined.  
After publication of this study, new ChIP-exo data were published where TATA-like 
elements were suggested [90]. Rhee and Pugh observed that 99% of the TATA-less  
TFIID-dominated promoters actually contain TATA-like elements differing only  
1-2 nt from the TATA box consensus sequence. TFIIB is positioned around this ele-
ment in a similar manner as around the TATA box [90]. Re-analysis of these pub-
lished data by in-house bioinfomaticians revealed that the found GAE is positioned 
slightly upstream of those TATA-like elements. The implication of that positioning is 
unclear but the GAE might assist in PIC formation.  
Second, the function of the guanine in the GAE is not clear. Since it does not impair 
TBP-TFIIB-DNA complex formation but does show a decreased functionality in vitro 
and in vivo, it must have a function independent from initial PIC assembly. It might be  
important for binding another protein which assists in orienting the PIC during the 
assembly or could support a distinct DNA conformation enhancing PIC assembly. In 
addition, it is not clear whether there is a GAE-specific binding protein or even pro-
teins specific for GAE-containing promoters.  
These points can be investigated by using the unbiased label-free mass spectrome-
try approach established in the PhD thesis of Martin Seizl [91]. In this approach, the 
GAE-containing and a GAE mutant or TATA box-containing promoter would be im-
mobilized on beads and incubated with nuclear extract. The bound proteins would 
then be washed and after elution differently labeled, followed by mass spectrometry 
analysis. Comparison of two data sets would show the enrichment of a distinct set of 
proteins specific for the GAE-containing promoter. Interestingly, in a publication some 
years ago about the ILV1 promoter region Moreira et al. described a protein called 
Datin. This binds to the poly(dA:dT) element of the ILV1 promoter and regulates its 
activity [92]. Inspection of this poly(dA:dT) element revealed that it is actually a GAE. 
This raises the possibility that Datin might bind to GAEs. Further binding studies such 
as EMSAs and the above mentioned mass spectrometry approach would be needed 
to investigate this hypothesis. 
As the consensus TATA box is only 8 nt in length, it would be interesting to deter-
mine the minimal GAE-containing sequence that is required to replace the TATA box 
and still shows transcriptional activity. To investigate this additional promoter con-
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structs have to be designed and tested in in vivo reporter assays and in vitro tran-
scription assays as described in this study. 
Finally, another remaining question is the possibility of additional core promoter ele-
ments correlating with the GAE. Further bioinformatic analysis would be required to 
identify those elements. 
 
In the second part of this study, four mutant variants of Brf1, a component of the 
general Pol III transcription factor TFIIIB, were characterized. TFIIIB is recruited by 
TFIIIC and recruits Pol III to promoters. It is composed of three proteins, namely 
TBP, Bdp1 and Brf1. Guntram Borck and colleagues from the University of Ulm iden-
tified biallelic point mutations in the human Brf1 in two pairs of siblings with cerebel-
lar, skeletal and dental anomalies. Each pair of siblings showed the same pair of mu-
tations, inherited in an autosomal-recessive manner.  
The N-terminal half of Brf1 is homologous to the Pol II transcription factor TFIIB and 
all of the described mutations are predicted to lie within a domain interacting with 
DNA. This study could show that these mutations lead to severe growth defects, re-
duce Brf1 recruitment at tRNA promoters and impair in vitro transcription in the yeast 
Saccharomyces cerevisiae. These results indicate that hypomorphic BRF1 mutations 
cause a neurodevelopmental syndrome, and that Brf1-mediated transcription by Pol 
III might be required for normal cerebellar and cognitive development. It is still un-
clear why these mutations lead to impaired transcription, hence, one of the main fu-
ture goals would be to study the underlying mechanism.  
One possible cause is a decreased affinity to DNA since in the hTFIIB homology 
structure two of the mutated residues are predicted to interact with DNA. Techniques 
to study DNA-binding, as EMSA or thermophoresis, would be an appropriate tool to 
investigate that hypothesis. Unfortunately, EMSAs are quite difficult to establish in 
this case and seem to depend on another Pol III transcription factor, TFIIIC [34, 93]. 
An approach developed in the group of Prof. Dr. Ulrike Gaul (Gene Center LMU) to 
test binding in solution, did not work due to aggregation. Hence no interaction be-
tween Brf1, TBP and DNA, respectively, was observed. Further optimization is 
needed to investigate these interactions.  
One of the mutations (Thr259Met) shows only a weak effect in in vitro transcription 
(decrease to 70%) but a severe growth defect and decreased recruitment to tRNA 
promoters. In contrast, another mutation (Ser226Leu) affects transcription strongly 
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(decrease to 35%) but leads to no growth defect and change in recruitment. The for-
mer might have a regulatory role in vivo and the latter might be suppressed in the in 
vivo context. It might be possible to study these variants and their effects on tran-
scription in a cell cycle dependent manner or upon a change in growth conditions. As 
reported by Fairley et al. Thr270 is phosphorylated during mitosis and represses 
Pol III-dependent transcription in human cells [94]. If this Thr is lost due to mutation, 
the repression is lost as well and transcription by Pol III is misregulated. Misregula-
tion of Pol III-dependent transcription can also lead to cancer [67]. However, it is 
possible that the role of Thr259 in regulation is yeast-specific.  
Interestingly, when these two mutant variants are introduced at the same time – as 
present in the affected children –yeast cells show impaired in vitro transcription, a 
growth defect and decreased recruitment of both Brf1 variants to tRNA promoters in 
vivo. Most likely, the simultaneous presence of the two mutations enhances the effect 
of the Ser226Leu mutation in vivo. In addition, Fairley et al reported that chromo-
some segregation is vulnerable to changes in Pol III-dependent transcription. Yeast 
cells harboring the mutations characterized in this study have the tendency to form 
aggregates without proper segregation of the cells. This might be another hint for 
implications of Pol III-dependent transcription in the cell cycle [94].  
Additionally, it would be interesting to investigate the mutant variants not only with 
ChIP followed by qPCR but also genome-wide by ChIP-seq or RNA sequencing to 
verify the trends seen on single tRNA genes and investigate their (putative) effect on 
gene expression. Moreover, the effect of these mutations on Bdp1 and TBP or Pol III 
recruitment to tRNA promoters could be tested via ChIP to see whether Pol III initia-
tion complex formation is disturbed. Complex formation could be investigated with 
purified factors in vitro as well. Finally, the mutations could be tested in a human sys-
tem in vivo and in vitro to confirm the observations made in yeast. To study the im-
pact of BRF1 mutations on development a Drosophila melanogaster model system 
could be used. 
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6 MATERIALS AND METHODS 
6.1 Materials 
6.1.1 Strains 
Table 4 Saccharomyces cerevisiae strains used in this study. 
ID Strain Genotype Source 
  
Wild type 
(BY4741) 
 
MATa; his31; leu20, 
met150; ura30 
 
 
Euroscarf (Y00000) 
 BRF shuffle MAT, ade2::hisG, his3200, 
leu20, lys20, met150, 
trp163, ura30, 
brf1::HIS3/pSH524 
Steve Hahn laborato-
ry [77] (SHY285) 
 
Table 5 Escherichia coli strains used in this study. 
Strain Genotype Source 
XL1-Blue Rec1A; endA1; gyrA96; thi-1; 
hsdR17; supE44; relA1; 
lac[F’proAB lacIqZM15 
tn10(Tetr)] 
Stratagene 
BL21-Codon Plus (DE3) 
RIL 
B; F-; opmT; hsdS(rs
- ms
-); 
dcm+; Tetr; gal (DE3); endA; 
Hte, [argU, ileY, leuW, Camr] 
Stratagene 
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6.1.2 Plasmids 
A detailed list with all plasmids generated is available through the Cramer laboratory. 
 
Table 6 Plasmids used for protein expression in E.coli. 
ID Insert Vector Restriction 
site 
Source 
1990 Sc BRF1 pOPINB KpnI, HindIII This study 
1991 Scbrf1 R218W pOPINB KpnI, HindIII This study 
1992 Scbrf1 A221S pOPINB KpnI, HindIII This study 
1993 Scbrf1 A221L pOPINB KpnI, HindIII This study 
1994 Scbrf1 T254M pOPINB KpnI, HindIII This study 
1995 Scbrf1 P288H pOPINB KpnI, HindIII This study 
1421 Sc Gcn4-6His pET21a  Steve 
Hahn labo-
ratory 
(pJF28) 
1986 Sc TBPcore pET  Lab stock 
1985 Sc TFIIB FL pOPINE NcoI, PmeI Lab stock  
 
Table 7 Plasmids used for yeast complementation assay (BRF knock out strain) 
and ChIP assays. 
ID Insert Vector Restriction 
site 
Source 
1997 Sc BRF (-500bp upstream from 
ATG and +500bp downstream 
from STOP codon) 
pRS315 NotI, SacI This study 
1998 Sc brf R218W(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
1999 Sc brf A221S(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
2000 Sc brf A221L(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
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ID Insert Vector Restriction 
site 
Source 
2001 Sc brf T254M(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
2002 Sc brf P288H(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
2003 Sc BRF-TAP (-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS315 NotI, SacI This study 
2004 Sc brf R218W-TAP (-500bp up-
stream from ATG and +500bp 
downstream from STOP codon) 
pRS315 NotI, SacI This study 
2005 Sc brf A221S-TAP (-500bp up-
stream from ATG and +500bp 
downstream from STOP codon) 
pRS315 NotI, SacI This study 
2006 Sc brf A221L-TAP (-500bp up-
stream from ATG and +500bp 
downstream from STOP codon) 
pRS315 NotI, SacI This study 
2007 Sc brf T254M-TAP (-500bp up-
stream from ATG and +500bp 
downstream from STOP codon) 
pRS315 NotI, SacI This study 
2008 Sc brf P288H-TAP (-500bp up-
stream from ATG and +500bp 
downstream from STOP codon) 
pRS315 NotI, SacI This study 
2009 Sc brf R218W(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS314 NotI, SacI This study 
2010 Sc brf A221L(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS314 NotI, SacI This study 
2011 Sc brf T254M(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS314 NotI, SacI This study 
2012 Sc brf P288H(-500bp upstream 
from ATG and +500bp down-
stream from STOP codon) 
pRS314 NotI, SacI This study 
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Table 8 Plasmids used for in vitro transcription assays. 
ID Insert Vector Restriction 
site 
Source 
792 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon)  HIS4 (TATA)
pBluescript 
KS+ 
HindIII/BamHI Lab stock  
1492 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) TATA mut to 
GGCCGGCC  HIS4 (GC-8) 
pBluescript 
KS+ 
HindIII/BamHI Lab stock  
2013 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) with 8bp TA-
TAbox replaced by 12bp GAE 
of TMT1 promoter  HIS4 
(GAE-12) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2014 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) with [-82] – 
[+24] replaced by [-188] – [+24] 
of TMT1 promoter sequence  
HIS4 (TMT1core) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2015 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) with 8bp TA-
TAbox -/+10 bp down/upstream 
replaced by 12bp GAE -/+ 10bp 
up/downstream of TMT1 promo-
ter  HIS4 (GAE-32) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2016 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) with [-157] – 
[+24] replaced by [-139] – [+24] 
of TMT1 promoter sequence  
HIS4 (TMT1down) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2017 native HIS4 promoter ([-428] – 
[+24] with respect to the A in 
the start codon) with [-133] – [-
45] replaced by [-113] – [-31] of 
TMT1 promoter sequence  
HIS4 (TMT1up) 
pBluescript 
KS+ 
HindIII/BamHI This study  
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ID Insert Vector Restriction 
site 
Source 
2020 native TMT1 promoter ([-273] – 
[+24] with respect to the A in 
the start codon)  TMT1 (GAE) 
pBluescript 
KS+ 
HindIII/BamHI Lab stock  
2021 native TMT1 promoter ([-273] – 
[+24] with respect to the A in 
the start codon) GAE mut 12bp 
 TMT1 (GC-12) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2022 native TMT1 promoter ([-273] – 
[+24] with respect to the A in 
the start codon) with 12bp GAE 
replaced by 8bp TATA box of 
the HIS4 promoter  TMT1 
(TATA) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2023 native TMT1 promoter ([-273] – 
[+24] with respect to the A in 
the start codon) with G to A in 
12bp GAE  TMT1 (A-12) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2031 Native SER3 promoter ([-230] – 
[+97] with respect to the A in 
the Inr region)  SER (TATA) 
pBluescript 
KS+ 
HindIII/BamHI Lab stock  
2032 Native SER3 promoter ([-230] – 
[+97] with respect to the A in 
the Inr region) TATAmut 
SER3 (GC-8) 
pBluescript 
KS+ 
HindIII/BamHI This study  
 
2033 Native SER3 promoter ([-230] – 
[+97] with respect to the A in 
the Inr region) with 8bp TATA-
box replaced by 12bp GAE of 
TMT1 promoter  SER3 (GAE) 
pBluescript 
KS+ 
HindIII/BamHI This study  
2034 Native SUP4 promoter ([-159] – 
[+244] with respect to TSS) 
pBluescript 
KS 
XhoI/BamHI This study  
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Table 9 Plasmids used for in vivo -Galactosidase reporter assay. 
ID Insert Vector Restriction 
site 
Source 
2035 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon)  HIS4 (TATA) 
pRS315 HindIII/BamHI Lab stock  
2036 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) TATA mut to 
GGCCGGCC  HIS4 (GC-8) 
pRS315 HindIII/BamHI Lab stock  
2037 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with 8bp TATA box 
replaced by 12bp GAE of TMT1 
promoter  HIS4 (GAE-12) 
pRS315 HindIII/BamHI This study  
2038 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with [-82] – [+24] 
replaced by [-188] – [+24] of 
TMT1 promoter sequence  
HIS4 (TMT1core) 
pRS315 HindIII/BamHI This study  
2039 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with 8bp TATAbox -
/+10 bp down/upstream replaced 
by 12bp GAE -/+ 10bp 
up/downstream of TMT1 promo-
ter  HIS4 (GAE-32) 
pRS315 HindIII/BamHI This study  
2040 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with [-157] – [+24] 
replaced by [-139] – [+24] of 
TMT1 promoter sequence  
HIS4 (TMT1down) 
pRS315 HindIII/BamHI This study  
2041 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with [-133] – [-45] 
replaced by [-113] – [-31] of 
TMT1 promoter sequence  
HIS4 (TMT1up) 
pRS315 HindIII/BamHI This study  
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ID Insert Vector Restriction 
site 
Source 
2042 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with GAE inserted 
at [-73] HIS4 (GAE-TATA) 
pRS315 HindIII/BamHI This study  
2043 native HIS4 promoter ([-428] – 
[+24] with respect to the A in the 
start codon) with GAE inserted 
at [-46] HIS4 (TATA-GAE) 
pRS315 HindIII/BamHI This study  
2044 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon)  TMT1 (GAE) 
pRS315 HindIII/BamHI Lab stock  
2045 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) GAE mut 12bp  
TMT1 (GC-12) 
pRS315 HindIII/BamHI This study  
2046 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with 12bp GAE re-
placed by 8bp TATA box of the 
HIS4 promoter  TMT1 (TATA) 
pRS315 HindIII/BamHI This study  
2047 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with G to A in 12bp 
GAE  TMT1 (A-12) 
pRS315 HindIII/BamHI This study  
2048 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with GAE (5bp)  
TMT1 (GAE) 
pRS315 HindIII/BamHI This study  
2049 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with 3nt down-
stream of GAE replaced by GCC 
 TMT1 (GC-3) 
pRS315 HindIII/BamHI This study 
2050 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with 4nt upstream of 
GAE replaced by GGCC  
TMT1 (GC-4) 
pRS315 HindIII/BamHI This study  
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ID Insert Vector Restriction 
site 
Source 
2051 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with GAE replaced 
by GGCCG  TMT1 (GC-5) 
pRS315 HindIII/BamHI This study  
2052 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with 4nt up-
stream/3nt downstream of GAE 
replaced by GGCC/ CGG  
TMT1 (GC-7) 
pRS315 HindIII/BamHI This study 
2053 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with GAE and 3nt 
downstream replaced by 
GGCCGGCC  TMT1 (GC-8) 
pRS315 HindIII/BamHI Lab stock 
2054 native TMT1 promoter ([-273] – 
[+24] with respect to the A in the 
start codon) with GAE and 4nt 
upstream replaced by 
GGCCGGCCG  TMT1 (GC-9) 
pRS315 HindIII/BamHI This study  
2055 native SER3 promoter ([-230] – 
[+97] with respect to the A in the 
Inr region)  SER (TATA) 
pRS315 HindIII/BamHI Lab stock  
2056 native SER3 promoter ([-230] – 
[+97] with respect to the A in the 
Inr region) TATAmut SER3 
(GC-8) 
pRS315 HindIII/BamHI This study  
2057 native SER3 promoter ([-230] – 
[+97] with respect to the A in the 
Inr region) with 8bp TATAbox 
replaced by 12bp GAE of TMT1 
promoter  SER3 (GAE) 
pRS315 HindIII/BamHI This study  
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6.1.3 Oligonucleotides 
A detailed list with all oligonucleotides used during this study is available through the 
Cramer laboratory. 
 
Table 10 List of Oligonucleotides used in this study. 
Oligonucleotide modification Sequence 5’ to 3’ 
EMSA 
HIS4(TATA) fw 
5’-Cy5 ACAGTAGTATACTGTGTATATAATA-
GATAT GGAACGTTAT 
EMSA 
HIS4(TATA) rev 
 ATAACGTTCC ATATCTATTA TATACA-
CAGT ATACTACTGT 
EMSA HIS4 
(GC-8) fw 
5’-Cy5 ACAGTAGTAT ACTGTGGGCC 
GGCCAGATAT GGAACGTTAT 
EMSA HIS4 
(GC-8) rev 
 ATAACGTTCC ATATCTGGCC 
GGCCCACAGT ATACTACTGT 
EMSA 
HIS4(GAE) fw 
5’-Cy5 TAGTATACTGTGAAAGGAAAAGGAA-
GATAT GGAACGTTAT 
EMSA 
HIS4(GAE) rev 
 ATAACGTTCC ATATCTTCCTTTTC 
CTTTCA CAGTATACTA 
EMSA 
TMT1(GAE) fw 
5’-Cy5 ATTTTCATTTTTAAAGGAAAAG-
GAATGTAA CTAATTTAGT 
EMSA 
TMT1(GAE) rev 
 ACTAAATTAG TTACATTCCT 
TTTCCTTTAA AAATGAAAAT 
EMSA 
TMT1(GC-12) fw 
5’-Cy5 ATTTTCATTT TTGGCCGGCC 
GGCCATGTAA CTAATTTAGT 
EMSA 
TMT1(GC-12) 
rev 
 ACTAAATTAG TTACATGGCC 
GGCCGGCCAA AAATGAAAAT 
EMSA 
TMT1(TATA) fw 
5’-Cy5 ATTTTCATTTTTTATATAATATGTAAC-
TAA TTTAGT 
EMSA 
TMT1(TATA) rev 
 ACTAAATTAG TTACATATTA TA-
TAAAAAAT GAAAAT 
EMSA TMT1 
(A-12) fw 
5’-Cy5 ATTTTCATTT TTAAAAAAAA 
AAAAATGTAA CTAATTTAGT 
EMSA TMT1 
(A-12) rev 
 ACTAAATTAG TTACATTTTT 
TTTTTTTTAA AAATGAAAAT 
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Oligonucleotide modification Sequence 5’ to 3’ 
Pol II in vitro 
transcription 
5’-Cy5 TTCACCAGTGAGACGGGCAAC 
Pol III in vitro 
transcription 
5’-Cy5 TCTCCCGGGGGCGAGTCGAACGCCC 
SOE1 TSS fw  TTTGTAATGGAATTTTTCCAAC 
SOE1 TSS rev  CGTGATGTGATAGCCGTTAC 
SNR6 TSS fw  CGTCCACTATTTTCGGCTA 
SNR6 TSS rev  GGTTACTTCGCGAACACAT 
SUP4 TSS fw  TCTCTTCCATCCCTTAGCTT 
SUP4 TSS rev  TAATTATCCGGTCCTTCCAA 
SUP56 TSS fw  AAACATTGTGACCCAAATATCA 
SUP56 TSS rev  AATCAGGCGCCTTAGACC 
SUF10 TSS fw  TGATGTTGAGGTACCATATTTTG 
SUF10 TSS rev  TCATACCTCTAGACCACACG 
YER heteroch-
romatin fw 
 TGCGTACAAAAAGTGTCAAGAGATT 
YER heteroch-
romatin rev 
 ATGCGCAAGAAGGTGCCTAT 
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6.1.4 Growth media and additives 
Table 11 Composition of Growth media used in this study. 
Growth medium Compostion Organism 
 
LB 
1% (w/v) trpytone; 0.5% 
(w/v) yeast extract; 0.5% 
(w/v) NaCl; (+2% (w/v) 
agar for selective media 
plates) 
Escherichiacoli 
YPD 2% (w/v) peptone; 2% 
(w/v) gluxose; 1% (w/v) 
yeast extract; (+2% (w/v) 
agar for selective media 
plates) 
Saccharomyces cerevi-
siae 
Synthetic complete (SC) 0.67% (w/v) yeast nitrogen 
base; 0.06% (w/v) com-
plete synthetic mix of ami-
no acids, drop out as re-
quired; 2% (w/v) glucose; 
(+2% (w/v) agar for selec-
tive media plates) 
Saccharomyces cerevi-
siae 
5-FOA plates SC; 0.01% (w/v) uracil; 
0.2% (w/v) 5-FOA; 2% 
(w/v) agar 
Saccharomyces cerevi-
siae 
 
Table 12 Antibiotic concentration in LB media. 
Antibiotic Concentration  
Ampicillin 100µg/ml 
Chloramphenicol 50µg/ml 
Kanamycin 30µg/ml 
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6.1.5 Buffers and solutions 
Table 13 General buffers and solutions. 
Buffer Composition 
TAE 40 mM tris acetate; 1 mM EDTA; pH 8.025°C 
TBE 8.9 mM Tris/HCl; 8.9 mM boric acid, 2 mM EDTA, 
pH 8.025°C 
TFB-1 30 mM KOAc; 50 mM MnCl2; 100 mM RbCl; 
10 mM CaCl2; 15% (v/v) glycerol; pH 5.8
25°C 
TFB-2 10 mM MOPS pH 7.025°C; 10 mM RbCl; 75mM 
CaCl2; 15% (v/v) glycerol 
TELit 155 mM LiOAc; 10 mM Tris/HCl pH 8.0; 1 mM 
EDTA pH 8.0 
LitSorb 18.2% (w/v) D-sorbitol in TELit pH 8.0 
LitPEG 40% (w/v) PEG 3350 in TELit pH 8.0 
MOPS running buffer 20 mM 3-(N-morpholino) propanesulfonic acid; 
5 mM sodium acetate·3H2O; 1 mM EDTA 
5x SDS sample buffer 250 mM Tris/HCl pH 7.025°C; 50% (v/v) glycerol; 
0.5% (w/v) bromophenol blue; 7.5% (w/v) SDS; 
500 mM DTT 
100x protease inhibitor cocktail 0.028 mg/ml leupeptin; 0.137 mg/ml pepstatin A: 
0.017 mg/ml PMSF; 0.33 mg/ml benzamidine; in 
100% ethanol p.a. 
 
Table 14 Buffers used for Gcn4 purification. 
Buffer Composition 
Lysis buffer 20 mM Tris/HCl pH 8.025°C, 500 mM NaCl, 5 mM 
DTT 
Buffer A 20 mM HEPES pH 7.525°C, 10% glycerol, 1 mM 
EDTA, 2 mM DTT 
Buffer B 20 mM HEPES pH 7.525°C, 150 mM potassium 
acetate, 10% (v/v) glycerol, 1 mM EDTA, 2 mM 
DTT 
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Table 15 Buffers used for TBP purification. 
Buffer Composition 
Lysis buffer/buffer A 25 mM Tris/HCl pH 8.025°C, 500 mM NaCl, 50 mM 
ammonium acetate, 10% glycerol 
Buffer B 25 mM Tris/HCl pH 8.025°C, 500 mM NaCl, 50 mM 
ammonium acetate, 10% glycerol; 250 mM imida-
zole 
Buffer C 25 mM Tris/HCl pH 8.025°C, 1 M NaCl, 50 mM 
ammonium acetate, 10% glycerol 
Pol II buffer 5 mM HEPES pH 7.2520°C, 40 mM (NH4)2SO4, 
10µM ZnCl2, 10mM DTT 
 
Table 16 Buffers used for TFIIB purification. 
Buffer Composition 
Lysis buffer 50 mM Tris/HCl pH 7.525°C, 300 mM NaCl, 5 mM 
imidazole, 10 µM ZnCl2, 2 mM DTT, 0.2% Tween-
20 
Wash buffer 50 mM Tris/HCl pH 7.525°C, 300 mM NaCl, 10 mM 
imidazole, 10 µM ZnCl2, 2 mM DTT,  
Elution buffer 50 mM Tris/HCl pH 7.525°C, 300 mM NaCl, 
200 mM imidazole, 10 µM ZnCl2, 2 mM DTT,  
Buffer A 50 mM Tris/HCl pH 7.56°C, 100 mM NaCl, 2 mM 
DTT 
Buffer B 50 mM Tris/HCl pH 7.56°C, 1 M NaCl, 2 mM DTT 
Pol II buffer 5 mM HEPES pH 7.2520°C, 40mM (NH4)2SO4, 
10µM ZnCl2, 10mM DTT 
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Table 17 Buffers used for Brf purification. 
Buffer Composition 
Lysis buffer 25 mM Tris/HCl pH 7.525°C; 200 mM KCl; 12.5 mM 
MgCl2; 10% (v/v) glycerol; 1x PI 
H.35 buffer 20 mM HEPES pH 8.025°C; 350 mM KCl; 2 mM 
MgCl2; 1% NaOH; 20% (v/v) glycerol; 0.1% (v/v) 
IGEPAL CA-630; 1x PI 
G6 buffer 100 mM Tris/HCl pH 7.54°C; 6 M GdmCl; 2 mM -
mercaptoethanol 
Ni-NTA elution buffer 100 mM Tris/HCl pH 7.54°C; 6 M GdmCl; 10 mM -
mercaptoethanol; 500 mM imidazole; 1xPI 
Dialysis buffer 20 mM tris acetate (80% cation = pH 7.54°C); 
200 mM KCl; 2 mM MgCl2; 20% (v/v) glycerol; 
0.1% (v/v); IGEPAL CA-630; 1xPI 
 
Table 18 Buffers used for electrophoretic mobility shift assay. 
Buffer Composition 
Binding buffer 4% glycerol, 4 mM Tris-HCl pH 8.023°C, 60 mM 
KCl, 5 mM MgCl2, 100 µg/ml BSA, 0.1% Tween 
20 
Protein dilution buffer 20 mM Tris pH 7.923°C, 150 mM KCl, 1 mM DTT, 
10% glycerol, 50 µg/ml BSA 
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Table 19 Buffers used for yeast nuclear extract preparation. 
Buffer Composition 
Resuspension buffer 50 mM Tris; 20 mM EDTA; 30 mM DTT; pH 7.5 
YPDS 1% (w/v) yeast extract; 2% (w/v) bactopeptone; 
2% (v/v) glucose; 1 M sorbitol 
Buffer A 18% (w/v) polysucrose 400; 10 mM Tris 
pH 7.525°C; 20 mM KOAc; 5 mM MgOAc; 1 mM 
EDTA pH 8.025°C; 0.5 mM spermidine; 0.15 mM 
spermine; 3 mM DTT; 1xPI 
Buffer B 100 mM Tris pH 7.925°C; 50 mM KOAc; 10 mM 
MgSO4; 20% glycerol; 2 mM EDTA 
Buffer C 20 mM HEPES pH7.625°C; 10 mM MgSO4; 1 mM 
EGTA pH 8.0; 20% glycerol 
Buffer C +NH4(SO4)2 20 mM HEPES pH 7.6
25°C; 10 mM MgSO4; 1 mM 
EGTA pH 8.0; 20% glycerol; 75 mM NH4(SO4)2 
 
Table 20 Buffer used for RNA polymerase II and III in vitro transcription assay. 
Buffer Composition 
5x transcription buffer 500 mM KOAc, pH 7.6; 100 mM HEPES pH 7.6; 
5 mM EDTA; 25 mM MgOAc 
Phosphocreatine (64mg/ml) 128 mg phosphocreatine; 2 ml TE pH 7.5; Add 
4 µl 1 M acetic acid, check pH with paper, should 
be ~7.5 
HA + 1M KOAc 20 mM HEPES pH 7.9; 10% glycerol;1 mM  
EDTA;100 mM KOAc;1 mM DTT 
5x primer annealing buffer 25 mM Tris pH 8.3; 375 mM KCl; 5 mM EDTA 
pH 8.0 
5x synthesis buffer 250 mM Tris pH 8.3; 375 mM KCl; 22.5 mM 
MgCl2; 75 mM DTT 
Formamide sample buffer 80% formamide; 25 mM EDTA; 1.5% bromophe-
nolblue 
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Table 21 Buffer used for chromatin immunoprecipitation. 
Buffer Composition 
TBS 50 mM Tris/HCl pH 7.54°C;150 mM NaCl 
FA-lysis buffer 150 50 mM HEPES pH 7.54°C; 1 mM EDTA; 1% Triton 
X-100; 0.1% sodium deoxycholate; 01% SDS; 
150 mM NaCl; 1x PI 
FA-lysis buffer 500 50 mM HEPES pH 7.54°C; 1 mM EDTA; 1% Triton 
X-100; 0.1% sodium deoxycholate; 01% SDS; 
500 mM NaCl  
Wash buffer 10 mM Tris/HCl pH 8.04°C; 0.25 M LiCl; 1 mM 
EDTA; 0.5% NP-40; 0.5% sodium deoxycholate 
Elution buffer 50 mM Tris/HCl pH 7.54°C; 10 mM EDTA; 1% SDS
PBS 137 mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 
1.8 mM KH2PO4; pH 7.4
25°C* 
TE 10 mM Tris/HCl pH 7.54°C; 1 mM EDTA 
LiCl wash buffer 100 mM Tris/HCl pH 7.54°C, 500 mM LiCl, 1% 
NP40, 1% sodiumdeoxycholate 
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6.2 Methods 
6.2.1 Molecular cloning 
Preparation of chemically competent Escherichia coli cells 
It is absolutely necessary to work sterile at all steps. E.coli XL-1 Blue or BL21(DE3), 
for plasmid preparation and protein overexpression, respectively, were grown in 
200 ml LB medium at 37°C. For growth of BL21 (DE3) Chloramphenicol was added. 
After reaching an OD600 of 0.5 the cells were put on ice for 10 min. All wash and cen-
trifugation steps were carried out at 4°C. The cells were centrifuged (4°C/ 
3000 g/10 min) and washed with 50 ml TFB-1. After centrifugation (4°C/ 
3000 g/10 min) the cell pellet was resuspended in 4 ml TFB-2. 50 µl aliquots were 
distributed in tubes on dry ice and afterwards stored at -80°C.  
 
Preparation of chemically competent Saccharomyces cerevisiae cells 
It is required to work sterile at all steps. A 50 ml culture was inoculated with an over-
night culture at start OD600 of 0,2 (150 rpm, 30°C). The cells were harvested (5 min, 
4,000 rpm, RT) and the supernatant discarded. The pellet was washed in 25 ml ste-
rile H2O and 5 ml LitSorb. Finally the pellet was resuspended in 360 µl LitSorb and 
mixed with 40 µl salmon sperm DNA. The salmon sperm DNA was heated at 100°C 
for 10 min and cooled down on ice before use. 50 µl aliquots were prepared and 
used directly or stored at -80°C. 
 
Polymerase chain reaction (PCR) 
A PCR primer introducing restriction sites usually encodes a 5’ overhang 
GGGCCCGGG followed bythe restriction site and a sequence complementary to the 
target sequence ensures specific amplification. In addition to the polymerase and 
0.2 mM dNTPs, MgCl2 and DMSO could be added to increase product yield. Chang-
ing the buffers is another option for optimizing the PCR condition. Taq polymerase 
and Phu polymerase were used depending on the required application. Typically 5-
10 ng of plasmid or 200 ng of yeast genomic DNA served as a template. Annealing 
temperature and elongation time were adjusted to the specific reactions. The biome-
tra T3000 thermocycler was used.  
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To visualize the PCR products they were run on a 1% Agarose gel (w/v) containing 
1:10 000 SYBR Safe DNA gel stain (Invitrogen)in 1xTAE buffer.  
The PCR products were purified using the QIAquick PCR Purification Kit (Qiagen) or 
QIAquick Gel Extraction Kit (Qiagen). 
 
Mutagenesis 
To introduce mutations the overlap extension PCR was used [95]. Two complemen-
tary oligonucleotides harboring the mutation embedded in 20-25 nucleotides up- and 
downstream of the respective sequence were designed. First, the up- and down-
stream region of the mutated site, respectively, including each time the desired muta-
tion was amplified in two independent PCRs. The PCR was carried out in the house-
made Phu master mix containing buffer, dNTPs and nucleotides. PCR products were 
purified via gel extraction. Subsequently the PCR products were used as a template 
with the flanking primer. The product contains the full length product and the desired 
mutation. 
 
Colony PCR in yeast 
For colony PCRs of yeast a pinhead size amount of yeast cells was suspended in 
100 µl 0.02 M NaOH. 50-100 µl soda lime glass beads (0.5 mm) were added. The 
sample was incubated for 10-15 min at 95°C vigorously shaking followed by a 5 min, 
full speed centrifugation step at room temperature. The supernatant can be used as 
a template for a PCR using the house-made Phu master mix. 
 
Restriction digest, dephosphorylation and ligation 
To perform the restriction digest, PCR products and vectors were usually incubated 
at 37°C at least one hour and maximum over night. Reaction buffers were chosen 
according to manufacturer’s manual. PCR products were purified using the QIAquick 
PCR purification kit (Qiagen).To the vector sample 1 unit alkaline phosphatase (Fas-
tAP by Fermentas) was added according to the manufacturer’s manual. Subsequent-
ly the restricted vector was purified using the QIAquick PCR purification kit (Qiagen). 
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To ligate the restricted vector and the PCR product they were mixed in a molar ratio 
of 1:5 with 10 units T4 Ligase as described in the manufacturer’s manual. Samples 
were incubated at 16°C for at least 2 hours. 
 
Transformation into Escherichia coli and plasmid preparation 
To transform ligation reactions and plasmids into chemically competent E.coli cells 
10 µl of ligation and 0.5 µl of purified plasmid, respectively, were added to a 50 µl cell 
aliquot. The cells were incubated on ice for 15 min followed by heat shock at 42°C for 
45 seconds. The cells were placed on ice again. After addition of 250 µl LB medium 
the cells were incubated at 37°C for 45 min, shaking with 600 rpm. The cell suspen-
sion was spread on plates containing the respective antibiotics and incubated at 
37°C. Plasmids were prepared from a 5 ml over night culture using the QIAprep Spin 
MiniPrep kit (Qiagen).  
To verify new constructs test restriction digest and DNA sequencing was applied. 
 
Transformation into Saccharomyces cerevisiae 
2 μl of plasmid DNA and 360 µl of LitPEGwere added to 10 μl cellsand incubated for 
30 min at RT. 8 µl DMSO were added before incubation for 15 min at 42°C. The cells 
were centrifuged (3 min, 2000 rpm, RT) and resuspended in 100 µl H2O. Cells were 
spread out on selection plates and incubated at 30°C or 24°C if the expected strains 
will be temperature sensitive.  
 
Yeast cryo stocks 
For yeast cryo stocks colonies from plates were resuspended in 30% sterile glycerol 
and frozen at -80°C. Do not flash-freeze in liquid nitrogen since this will lead to cell 
death. 
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6.2.2 General protein methods 
Protein overexpression 
Gcn4 
Proteins were expressed in E.coli BL21-Codon plus (DE3) RIL cells. The expression 
plasmid (see Table 6) was transformed and cells were grown on Ampicillin and Chlo-
ramphenicol media plates. The 3 l main culture was inoculated at OD600 0.1 with a 
preculture in LB medium containing Ampicillin and Chloramphenicol. The cells were 
grown at 37°C and 140 rpm shaking. Before protein expression cells were cooled 
down in cold room on ice. Protein expression was induced with 0.5 mM IPTG at an 
OD600 0.7. Cells were grown over night at 18°C and harvested (20 min, 4000 rpm, 
4°C). Pellet was washed with 40 ml LB medium and pelleted (10 min, 4000 rpm, 
4°C). Pellet was flash-frozen in liquid nitrogen and stored at -80°C. 
 
TBP 
TBP core with an N-terminal His-tag (amino acids 61-240, a gift from Z. S. Juo) was 
transformed into Rosetta (DE3) pLysS cells and cells were grown on Ampicillin and 
Chloramphenicol plates. The 4 l main culture was inoculated at OD600 0.1 with a pre-
culture. The cells were grown at 37°C, 140 rpm. Protein expression was induced with 
1 mM IPTG at OD600 0.7 at 20°C. The cells were harvested after 18 h (20 min, 
4 000 rpm). The pellet can be flash-frozen in liquid nitrogen and stored at -80°C. 
 
TFIIB 
TFIIB with an N-terminal His-tag on the pOPINE vector was transformed into Rosetta 
(DE3) pLysS cells and cells were grown on Ampicillin and Chloramphenicol plates. 
The 1 l main culture was inoculated at OD600 0.1 with a preculture. The cells were 
grown at 37°C, 140 rpm. Protein expression was induced with 1 mM IPTG at OD600 
0.6 at 20°C. The cells were harvested after 18 h (20 min, 4 000 rpm). The pellet can 
be flash-frozen in liquid nitrogen and stored at -80°C. 
 
Brf1 
Proteins were expressed in E.coli BL21-Codon plus (DE3) RIL cells. The respective 
expression plasmids (see Table 6) were transformed and cells were grown on Ka-
namycin and Chloramphenicol media plates. The 2 l main culture was inoculated at 
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OD600 0.1 with a preculture in LB medium containing Kanamycin and Chlorampheni-
col. Cells were grown at 37°C and 140 rpm shaking. Protein expression was induced 
with 1 mM IPTG at an OD600 0.7. Cells were grown for further 3 h and harvested 
(20 min, 4000 rpm, 4°C). The pellet was washed with 40ml LB medium and centri-
fuged again (10 min, 4000 rpm, 4°C). The pellet was flash-frozen in liquid nitrogen 
and stored at -80°C. 
 
Cell lysis 
For cell disruption the cell pellets were thawed on ice and resuspended in 50 ml lysis 
buffer. Afterwards they were placed on ice and lysed by sonication (40 output value, 
25% duty cycle, 15 min). Finally the insoluble fraction was separated from the soluble 
fraction by centrifugation (30 min, 15 000 rpm, 4°C). 
 
Protein concentration determination 
Nanodrop 
Gcn4 protein concentration was calculated from absorbance at 280 nm using the 
specific absorption coefficient. This was calculated using ProtParam [96].Absorbance 
was measured with a NanoDrop spectrophotometer. 
 
Bradford 
For the Brf1 protein and its variants the concentration was determined with the help 
of the Bradford assay [97]. All samples were treated according to the manufacturer’s 
manual (Bio-Rad). 
For each batch of dye solution a separate standard curve was measured with bovine 
serum albumin (Roth). 
 
SDS-Polyacrylamide gel electorphoresis (SDS-PAGE) 
Proteins were analyzed on 4-12% gradient pre-casted NuPAGE Novex Bis-
Trisminigels (Invitrogen) in a Bio-Rad gel system. Gels were run in MOPS buffer for 
45 min at 200V. SDS buffer [98]was added and samples were boiled for 2 min at 
95°C before loading on the gel. Gels were stained in InstantBlue (expedion). 
6 MATERIALS AND METHODS 
 
 
64  
 
Mass spectrometry 
To identify purified proteins and their potential impurities protein samples were sepa-
rated by SDS-PAGE. The bands of interest were excised and sent to the protein 
analysis core facility (Adolf-Butenandt-Institut, LMU) for analysis.  
 
6.2.3 Recombinant protein purification 
Gcn4 purification 
For composition of buffers please see Table 14. 
After cell lysis, the lysate was cleared by centrifugation (30 min, 15 000 rpm, 4°C). 
The supernatant was loaded twice onto a 2 ml Ni-NTA column (Qiagen) equilibrated 
with lysis buffer. The column was washed three times with 10 column volumes (CV) 
of lysis buffer containing 20 mM imidazole. Bound protein was eluted with 10 CV of 
lysis buffer containing 500 mM imidazole. Protein was further purified by cation ex-
change chromatography using a HiTrap SP column (GE Healthcare) equilibrated with 
buffer A. The protein was eluted with a linear gradient of 10 CVs from 0 to 1 M NaCl 
in buffer A. After concentration, the sample was applied to a Superdex 200 size ex-
clusion column (Amersham) equilibrated with buffer B. The sample was concentrated 
to approximately 0.5 mg/ml, flash-frozen in small aliquots in liquid nitrogen, and 
stored at -80°C. All buffers contained protease inhibitor cocktail. 
 
TBP purification 
For composition of buffer please see of buffer please see Table 15. 
After cell lysis the sample was cleared by centrifugation (30 min, 15 000 rpm, 4°C). 
The supernatant was loaded onto 2 ml Ni-NTA bead resin (Qiagen) and washed with 
7.5 CV of buffer A. The proteins were eluted with 3 CV buffer B and the conductivity 
was adjusted to the conductivity of buffer A. The sample was loaded onto a 5 ml He-
parin column and wash with buffer A until it reaches the baseline. The proteins were 
eluted in 1 ml fractions over a 5 CV gradient from buffer A to buffer C. The peak frac-
tion contains TBP which is pooled and applied to a Superdex 75 10/300 GL size ex-
clusion column. The column was run in Pol II buffer. The TBP-containing fractions 
were combined and flash-frozen in liquid nitrogen. TBP can be stored at -80°C.  
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TFIIB purification 
For the composition of buffers please refer to Table 16. 
The cell pellet was resuspended in 30 ml lysis buffer and lysed by sonication. The 
supernatant was centrifuged twice for 30 min, 15 000 rpm, 4°C and bound in batch to 
2 ml Ni-NTA bead volume (Qiagen) for 20 min at 4°C. The beads were washed with 
10 CV wash buffer on a gravity flow column. The protein was eluted with 3 CV elution 
buffer. Before loading the protein sample on a MonoS 10/100 GL column its conduc-
tivity was adjusted to buffer A and it was filtered. The proteins were eluted in 1 ml 
fractions over a 15 CV gradient from 0 to 100% buffer B. The peak fraction containing 
TFIIB was pooled and concentrated to a volume of 700 µl for loading on the size ex-
clusion column Superdex 75 10/300 GL. The protein sample was separated over 
1.5 CV in Pol II buffer. The peak fraction containing TFIIB was collected, concentra-
tion determined and samples were frozen in liquid nitrogen. 
 
Brf purification 
For composition of buffers please see of buffers please see Table 17. 
The cells were thawed on ice and resuspended in 50 ml lysis buffer. Subsequently 
0.8 mg lysozyme (Roth) per ml lysate was added and incubated rotating in the cold 
room. After 10 min 0.2% IGEPAL CA-630 (MP Biomedicals) was added for further 
5 min. For cell disruption lysate was transferred into a glas beaker and sonicated for 
15 min, 25% duty cycle and 40 output value. Afterwards the lysate was centrifuged 
(30 min, 17 500 rpm, 4°C) and the supernatant removed. The pellet contained Brf1 in 
inclusion bodies. Upper layer of white and grey pellet was removed and the remain-
ing parts were washed twice in H.35 buffer. Inclusion bodies were extracted with 5 ml 
G6 buffer and rotation for 1 h at 4°C. To remove insoluble parts the sample was cen-
trifuged (15 min, 15 000 rpm, 4°C). The supernatant was bound in batch to 2.5 ml Ni-
NTA bead volume in G6 buffer over night at 4°C. Beads were washed with 12.5 ml 
G6 buffer and protein eluted in batch with three times 2.5 ml Ni-NTA elution buffer. 
To the combined eluate ZnSO4 and DTT were added to final concentrations of 10 µM 
and 5 mM respectively. Finally the denatured Brf1 was refolded via rapid dilution and 
dialysis. For rapid dilution 100 µl of the eluate was placed in the lid of a 1.5 ml Ep-
pendorf tube containing 1 ml dialysis buffer. The lid was closed and the tube flipped 
around quickly. For every tube this could be repeated twice. After rapid dilution the 
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protein was dialyzed in dialysis buffer followed by centrifugation (15 min, 15 000 rpm, 
4°C) to remove aggregated proteins. Since concentrating the protein was not possi-
ble aliquots were directly frozen in liquid nitrogen and stored at -80°C. Usually the 
purification resulted in 30 ml of 0.4 – 0.8 mg/ml protein solution. 
 
6.2.4 Biochemical assays 
Nuclear extract preparation 
Nuclear extracts were prepared from 3 l of BY4741 wild type yeast culture or 
SHY285, a Brf1 knock-out strain containing a Brf1 W107R mutation on a plasmid as 
described [99]. 
Brf1 W107R yeast strain could be grown at 30°C. Composition of buffers can be 
found in can be found in Table 19. 
Yeast cells were grown to an OD600 3-5 and harvested (10 min, 4 000 rpm, 18°C). 
The supernatant was discarded and the pellet resuspended in 35 ml resuspension 
buffer. The cell suspension was incubated for 15 min in a 30°C water bath and pel-
leted again (10 min, 4 000 rpm, 18°C). Pellets were resuspended in 20 ml YPDS and 
3 ml of 2 M sorbitol was added. Cell wall disruption was achieved by adding 3 ml re-
suspension buffer containing 18 mg Zymolyase, 1xPI and 1xPMSF and incubating for 
30 min in a 30°C water bath. Progress of the cell wall disruption was followed by 
measuring OD600. The value should decrease by 70 – 80%. 100 ml YPDS were add-
ed and spheroblasts pelleted for 10 min, 4 000 rpm, 18°C. Cells were resuspended in 
250 ml YPDS and again incubated for 30 min in a 30°C water bath. From now on all 
following steps were carried out at 4°C. After centrifugation (10 min, 4 000 rpm, 
18°C) cells were washed twice in 200 ml YPDS and once in 250 ml 1 M Sorbitol. Af-
ter the final wash cells were resuspended in 100 ml buffer A. The cell membrane was 
disrupted by passing the suspension three times through a pre-chilled Dounce glass 
homogenizer with a narrow pestle. The crude nuclei were isolated by centrifugation 
(8 min, 5 000 rpm, 4°C) in GSA bottles. This step was repeated twice and each time 
the pellet was discarded. Supernatant was transferred to SS34 tubes and the nuclei 
were pelleted (30 min, 13 000 rpm, 4°C). The nuclei were resuspended in 15 ml buf-
fer B and washed once with 15 ml buffer B. The nuclei can be flash-frozen in liquid 
nitrogen at that point and stored at -80°C.  
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The frozen nuclei were thawed in the cold room on a spinning wheel. To disrupt the 
nuclear membrane 3 M ammonium sulfate solution was added to a final concentra-
tion of 0.5 M. Samples were incubated for 30 min in the cold room on a spinning 
wheel. After centrifugation (90 min, 28 000 rpm, 4°C – SW28 tubes) all proteins in the 
supernatant were precipitated by addition of 0.35 g solid ammonium sulfate per ml 
supernatant. Again the samples were incubated for 30 min in the cold room. To pellet 
the precipitated proteins the solution was centrifuged in SW28 tubes again (20 min, 
28 000 rpm, 4°C). The supernatant was removed and samples re-spun (5 min, 
10 000 rpm, 4°C). The pellet contained all nuclear proteins and was resuspended in 
a maximum of 1.5 ml buffer C. The nuclear extract was dialyzed over 4.5 hours in 
500 ml buffer C + (NH4)2SO4 with buffer exchange every 1.5 hours. Afterwards the 
nuclear extract was aliquoted and flash-frozen in liquid nitrogen. Protein concentra-
tion was determined after first freeze and appropriate dilution with 0.1% SDS with 
Bradford. 
 
RNA polymerase II in vitro transcription 
In vitro transcription and analysis by primer extension were performed as described 
[99]. Template plasmids were generated by inserting the respective promoter se-
quence as described above in pBluescript KS+ with HindIII and BamHI (Table 8). 
Primer extension for all constructs was done using the same 5’-Cy5-labeled oligonuc-
leotide (Table 10). The composition of the buffers can be found inTable 20. For the in 
vitro transcription reaction 1x transcription buffer, 2.5 mM DTT, 150 ng template, 
192 µg phosphocreatine, 0.2 µg creatine phosphokinase, 10 U RiboLock RNase inhi-
bitor (Fermentas) and 200 ng recombinant full-length Gcn4 were mixed. Gcn4 was 
allowed to bind to the template for 10 min at 18°C. Afterwards 200 µg yeast nuclear 
extract wild type were added and transcription initiated by addition of 0.1 mM NTPs. 
The total reaction volume was 25 µl. Transcription reaction was stopped by RNA iso-
lation using the RNeasy MinElute kit (Qiagen) according to the manufacturer’s ma-
nual. For primer annealing 1x annealing buffer and 0.125 pmol primer were added to 
the isolated RNA (total volume: 20 µl). The samples were boiled for 2 min at 95°C 
and incubated for 45 min at 48°C. Before primer extension 2µg Actinomycin D were 
added, followed by 1x synthesis buffer, 0.1 mM dNTPs and 0.25 U MuLV reverse 
transcriptase (Roche) resulting in a volume of 60 µl. Primer were extended for 30 min 
6 MATERIALS AND METHODS 
 
 
68  
 
at 48°C. The resulting cDNA was isolated via ethanol precipitation. The dried pellet 
was resuspended in 4 µl 0.04 mg/ml RNase A and 4 µl formamide sample buffer. 
Before loading samples were boiled for 2 min at 95°C and directly put on ice.  
Samples were run on a 7 M urea, 8% polyacrylamide (35:1) gel in 1x TBE for 45 min, 
180 V. The gel was pre-run for 5 to 10 min and the pockets were rinsed before load-
ing.  
Gels were analyzed with a typhoon scanner FLA9400 and ImageQuant Software (GE 
Healthcare). 
 
RNA polymerase III in vitro transcription 
The in vitro transcription for RNA polymerase III was basically done as described for 
RNA polymerase II. The template contained the SUP4 gene from [-159] – [+244] with 
respect to the transcription start site of the tRNA. SUP4 encodes for one tyrosine 
tRNA. The transcription reaction contained 1x transcription buffer, 2.5 mM DTT, 
150 ng template, 192 µg phosphocreatine, 0.2 µg creatine phosphokinase, 10 U Ri-
boLock RNase inhibitor (Fermentas), 50µg temperature-sensitive nuclear extract - 
harboring a temperature-sensitive W107R mutation in Brf -, 40 µM -amanitin and 
100 ng of recombinant protein where indicated. Proteins were added to the transcrip-
tion reaction mix for 5 min before addition of NTPs. The transcription reaction was 
carried out at 30°C. The primer was annealed at 60°C. All other following steps were 
performed as described above. 
 
Electrophoretic mobility shift assay (EMSA) 
EMSAs were performed as described [100] with minor modifications. Templates were 
generated by annealing the complimentary PAGE-purified oligonucleotides (coding 
strand was 5’-Cy5-labeled, Table 10). The buffer composition can be found in Table 
18. The binding reaction contained 3 nM of 40 bp 5’-Cy-5-labeled dsDNA, 300 nM 
TBPcore and 3 µM TFIIB, 1 mM DTT, 50 µg/ml Heparin in 1x binding buffer in a total 
reaction volume of 20 µl. Recombinant TBPcore and TFIIB were expressed in E.coli 
and purified as described [101]. Proteins were diluted in dilution buffer. Samples 
were incubated for 30 min at 18°C and loaded on a 6% native polyacrylamide gel 
(acrylamide:bisacrylamide 60:1, 190 mM glycine, 25 mM Tris pH 8.323°Cwith acetic 
6 MATERIALS AND METHODS 
 
 
69  
 
acid, 0.5 mM DTT, 0.1% APS, 1% TEMED). The gel was pre-run for 5 min and then 
run at 160 V for 15 min at room temperature in 190 mM glycine, 25 mM Tris 
pH 8.323°C. The gels were analyzed with a typhoon scanner FLA9400 and Image-
Quant Software (GE Healthcare). 
 
In vivo reporter assay in yeast 
The native promoter sequences of HIS4 (428 bp upstream to 24 bp downstream of 
the start codon) and TMT1 (273 bp upstream to 24 bp downstream of the start co-
don) and their mutant variants were cloned between HindIII/BamHI into a pRS315 
plasmid a pRS315 plasmid (see Table 9) with the lacZ gene inserted between No-
tI/SalI. The reporter plasmids were transformed into BY4741 wild type yeast cells and 
grown in biological duplicates in SD (–leu) medium to an OD600 of 0.5-1.0. β-
galactosidase levels were determined using the Yeast β-galactosidase Assay Kit ac-
cording to the manufacturer’s manual (Thermo Scientific, #75768). 
 
Chromatin immunoprecipitation 
For compositions of buffer please refer to Table 21. Experiments were basically done 
as described [102] with minor modifications.  
For the ChIP assay TAP-tagged Brf1 and its mutant variants were introduced in the 
vector pRS315 which contains Brf expressed under the control of its own promoter. 
For combinations of the mutations S226L and T259M were cloned into pRS314 vec-
tor and co-transformed with the TAP-tagged Brf variants T259M-TAP and S226L-
TAP in the pRS315 vector, respectively.  
For duplicates two colonies from one plate were grown to an OD600 0.8 in 50 ml. 1 ml 
37% formaldehyde (Sigmal-Aldrich) was added and the cell suspension shook for 
20 min at 20°C. To stop cross-linking 5 ml 3 M glycine (pre-warmed to 30°C) were 
added and the cell suspension shook for further 5 min at 20°C. The cells were har-
vested (5 min, 4 000 rpm; 4°C) and pellets washed with 20 ml ice-cold TBS, 2 ml ice-
cold FA-lysis buffer 150 and 1 ml ice-cold FA-lysis buffer 150. The supernatant was 
discarded and the pellet flash-frozen in liquid nitrogen. The pellets can be stored at -
80°C. For further treatment the cells were thawed on ice and resuspended in ice-cold 
FA-lysis buffer 150. To 1 ml cooled down Zirconia beads (0.5 mm diameter, BioSpec 
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products) in 2 ml DNase free tubes 1 ml cell suspension was added. The cells were 
lysed by bead beating (Retsch) for 30 min, 30/sec at 4°C in the cold room. The solu-
tion containing the chromatin was separated from the beads by punching a hole in 
the bottom and top of the tube and centrifuging (1 min, 1 000 rpm, 4°C) into a 15 ml 
Bioruptor tube. 200 µl ice-cold FA-lysis buffer 150 were added. The chromatin was 
fragmented by sonication for 35 cycles, 30 seconds on/off, high intensity in the Bio-
rupter (daigenode). Afterwards the samples were centrifuged for 10 min, 13 000 rpm, 
4°C and the supernatant was transferred into a new DNase free tube and centrifuged 
for a second time (30 min, 13 000 rpm, 4°C). The chromatin concentration was 
measured with Nanodrop. 100 µl of chromatin solution can be used for fragment size 
control on a 1% agarose gel. 30 µl of the chromatin solution were transferred to a 
0.5 ml low binding tube and labeled as input. 670 µl chromatin solution were added to 
100 µl magnetic beads with coupled anti-rabbit IgG and labeled as IP (immunopreci-
pitation).  
Magnetic beads were prepared as follows. If the IgG was frozen it needs to be centri-
fuged (20 min, 15 000 rpm, 4°C) and the concentration newly determined. 18 µl of 
Dynabeads Protein G (invitrogen) per IP were washed four times with 500 µl PBS 
containing 5 mg/ml BSA. Beads for more than one IP can be prepared together. Fi-
nally beads were resuspended in a total volume of 500 µl PBS containing 5 mg/ml 
BSA and 82.5 µg antibody per 100 µl beads. The antibody was allowed to bind for 
30 min at 4°C on a rotating wheel. The coupled antibody was washed three times 
with 500 µl PBS containing 5 mg/ml BSA and resuspended in 109 µl PBS containing 
5 mg/ml BSA per 18 µl beads.  
The IP (670 µl chromatin solution plus 100 µl magnetic beads with coupled antibody) 
was carried out for 1 hour at 4°C on a rotating wheel. The beads were washed five 
times with 1 ml LICl wash buffer and once with 1 ml TE. Every time they were al-
lowed to mix with the buffer for 3 min on a rotating wheel. Finally the beads were re-
suspended in 120 µl ChIP elution buffer, vortexed and incubated for 5 min at 95°C. 
The supernatant was transferred to a 0.5 ml low binding tube labeled IP. 
Cross-links of IP samples were reversed by addition of 80 µl TE and 20 µl Proteinase 
K (20 mg/ml, Sigma). To ‘input’ samples 100 µl ChIP elution buffer, 60 µl TE and 
20 µl Proeinase K were added. Both samples were incubated for 2 hours at 37°C and 
over night at 65°C.  
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The DNA was purified using the Qiaquick PCR Purification Kit (Qiagen) with the ex-
ception that DNA was loaded with 3 000 rpm for 1 min onto the columns. The DNA 
was eluted with 50 µl H2O. 
For analysis of chromatin fragments quantitative real time PCR (qPCR) was applied. 
A typical qPCR reaction mix contained 10 µl SensiFast Sybr NO-ROX Kit (Bioline), 
0.8 µl forward primer (10 pmol/µl), 0.8 µl reverse primer (10 pmol/µl) and 7.4 µl H2O. 
The reaction was performed on a CFX96 Real-Time System (Bio-Rad) using a 3 min 
denaturing step at 95°C followed by 49 cycles of 30 seconds 95°C, 30 seconds 61°C 
and 15 seconds at 72°C. The threshold cycle values (Ct) were determined using the 
Ct determination mode ‘regression’ of Bio-Rad CFX Manager software package (ver-
sion 3). The fold enrichment over a heterochromatic control region was determined 
and calculated as described[103]. 
 
Yeast complementation assay for BRF mutations 
To introduce Brf1 mutations in yeast the shuffle vector system developed by Sikorski 
and Hieter was used [104]. Brf1 mutations were introduced in the vector pRS315, 
which contains yeast Brf1 expressed under the control of its own promoter (see Ta-
ble 7). Mutations were introduced using site-directed mutagenesis and confirmed by 
DNA sequencing. The identified mutations from humans (h) were transferred to yeast 
(y). The corresponding numbers are as follows: hR223 = yR218, hS226 = yA221, 
hT259 = yT254, hP292 = yP288. For combinations of the mutations Brf1 variants 
T259M and S226L were cloned into pRS314 vector and co-transformed with the 
S226L and T259M mutation in the pRS315 vector, respectively. Plasmids were trans-
formed into the yeast strain SHY285 and the wild type BRF1 gene was replaced with 
the mutant gene by plasmid shuffle at 30°C. Cells were spread on selective media 
and restreaked twice on selective media plates containing 5-FOA. Cells were tested 
for growth phenotypes on synthetic complete glucose plates (-leucine and –
leucine/tryptophane for combinations) at 30°C. For spot dilutions an equal amount of 
yeast cells was tenfold diluted in a serial dilution and spotted on YPD plates. Subse-
quently plates were incubated at 30°C. 
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APPENDIX 
List of Sc promoters containing the identifed GA element described and characte-
rized in chapter 2.  
YAL002W 
YAL007C 
YAL012W 
YAL016W 
YAL018C 
YAL020C 
YAL023C 
YAL025C 
YAL027W 
YAL033W 
YAL035W 
YAL053W 
YAL055W 
YAL056W 
YAL058W 
YAR002C‐A 
YAR002W 
YAR007C 
YAR023C 
YAR027W 
YAR028W 
YAR033W 
YBL004W 
YBL006C 
YBL007C 
YBL010C 
YBL011W 
YBL023C 
YBL026W 
YBL028C 
YBL034C 
YBL039W‐B 
YBL040C 
YBL045C 
YBL051C 
YBL056W 
YBL058W 
YBL061C 
YBL068W 
YBL069W 
YBL071W‐A 
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YBL090W 
YBL093C 
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YBL105C 
YBR003W 
YBR009C 
YBR014C 
YBR015C 
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YBR019C 
YBR022W 
YBR024W 
YBR034C 
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YBR057C 
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YBR077C 
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YBR097W 
YBR101C 
YBR103W 
YBR111W‐A 
YBR123C 
YBR127C 
YBR138C 
YBR142W 
YBR143C 
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YBR153W 
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YDL074C 
YDL076C 
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YDR477W 
YDR478W 
YDR481C 
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YDR486C 
YDR488C 
YDR494W 
YDR495C 
YDR496C 
YDR497C 
YDR510W 
YDR511W 
YDR522C 
YDR524C 
YDR530C 
YEL002C 
YEL003W 
YEL004W 
YEL006W 
YEL013W 
YEL015W 
YEL016C 
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YEL018W 
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YEL024W 
YEL025C 
YEL026W 
YEL027W 
YEL036C 
YEL040W 
YEL044W 
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YEL059C‐A 
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